ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 2 of 52  
 
 
 
 
 
ATN 139 - Get Connected: Linking YMSM to Adequate Care through a Multi -level Tailored 
WebApp Intervention  
 
 
 
 
  SIGNATURE PAGE  
 
 
I will conduct the study in accordance with the provisions of this protocol and all applicable 
protocol -related documents. I agree to conduct this study  in compliance with United States (US) 
Health and Human Service regulations (45 CFR 46); applicable U.S. Food and Drug 
Administration regulations; standards of the International Conference on Harmonization Guideline for Good Clinical Practice (E6); Institu tional Review Board/Ethics Committee determinations; all 
applicable in- country, state, and local laws and regulations; and other applicable requirements 
(e.g., US National Institutes of Health, Division of AIDS) and institutional policies.  
 
 
Investigator  of Record : _______________________________________________ 
Print/Type  
 
 
 
 
Signed: ___________________________________ Date: ____________________ 
 
 
Title: _____________________________________ 
 
 
 
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 3 of 52   
TABLE OF CONTENTS  
SIGNATURE PAGE  ........................................................................................................................ 2 
TABLE OF CONTENTS  ................................................................................................................. 3 
PROTOCOL TEAM ROSTER  ........................................................................................................ 6 
PRIMARY SITE CONTACT  FOR PROTOCOL  ............................................................................ 7 
LIST OF ABBREVIATION S AND DEFINITION OF TERMS  .................................................... 8 
STUDY ABSTRACT  ....................................................................................................................... 9 
1.0 INTRODUCTION  .................................................................................................................... 12 
1.1  Background ................................................................................................................................. 12 
1.2  Rationale  ..................................................................................................................................... 12 
2.0 STUDY OBJECTIVES  ............................................................................................................ 15 
2.1  Primary Objective:  ...................................................................................................................... 15 
2.2  Secondary Objective:  .................................................................................................................. 15 
2.3  Tertiary Objective:  ...................................................................................................................... 15 
2.4  Study Hypotheses/Research Questions  ....................................................................................... 15 
3.0 STUDY DESIGN ........................................................................................................... 17 
3.1 Study Phases  ................................................................................................................................... 17 
3.2  Study P opulation  ......................................................................................................................... 21 
3.3 Sample Size  ................................................................................................................................ 22 
3.4 Study Randomization, Stratification, or Description of Non- Random Assignment Procedures  22 
4.0 ELIGIBILITY AND SCREENING  ......................................................................................... 22 
4.1 Primary Objective (RCT):  Inclusion Criteria  ............................................................................ 22 
4.2 Primary Objective (RCT):  Exclusion Criteria  ........................................................................... 23 
4.3 Secondary Objective (Mystery Shoppers): Inclusion Criteria  .................................................... 23 
4.4 Secondary Objective (Mystery Shoppers): Exclusion Criteria  ................................................... 23 
4.5 Tertiary Objective (Site Directors): Inclusion Criteria  ............................................................... 24 
4.6 Tertiary Objective (Site Directors): Exclusion Criteria  .............................................................. 24 
4.7 Recruitment  ................................................................................................................................ 24 
4.8 Informed Consent  ....................................................................................................................... 24 
4.9 Screening  .................................................................................................................................... 26 
5.0 STUDY PROCEDURES  .......................................................................................................... 26 
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 4 of 52 5.1 Enro llment Procedures  ............................................................................................................... 26 
5.2 Locator/Contact Information  ...................................................................................................... 27 
5.3 Randomization Procedures  ......................................................................................................... 27 
5.4 Intervention/Investigation Procedures  ........................................................................................ 28 
6.0 EVALUATIONS AND MEASURES  ...................................................................................... 29 
6.1 Behavioral Evaluations  ............................................................................................................... 29 
7.0 DATA COLLECTION AND SITE MONITORING  ............................................................... 32 
7.1 Development of Protocol and Case Report Forms  ..................................................................... 32 
7.2 Data Records  ............................................................................................................................... 32 
7.3  Data Collection  ........................................................................................................................... 32 
7.4 Data  Submission  ......................................................................................................................... 35 
7.5 Data Quality Assurance  .............................................................................................................. 36 
7.6 Role of Data Management  .......................................................................................................... 36 
7.7 Study Site Monitoring and Record Availability  ......................................................................... 36 
8.0  PARTICIPANT MANAGEME NT ................................................................................ 37 
8.1 Tracking RCT Participants for Follow -up .................................................................................. 37 
8.2 Compensation  ............................................................................................................................. 37 
8.3 Intervening on “Social Harms"  ................................................................................................... 37 
8.4 Criteria for Premature Study Discontinuation  ............................................................................ 38 
9.0 MONITORING UNTOW ARD EFFECTS ASSOCIAT ED WITH OR RESULTING FROM 
STUDY .......................................................................................................................... 39 
10.0 STATISTICAL/ANA LYTIC CONSIDERATIONS  ............................................................. 39 
10.1  Introduction  ................................................................................................................................ 39 
10.2  Power Estimates  ......................................................................................................................... 40 
10.3  Statistical Analysis Plan  ............................................................................................................. 40 
10.4  Missing Data  ............................................................................................................................... 41 
11.0 HUMAN SUBJECTS  ............................................................................................................. 41 
11.1  Participants’ Confidentiality  ....................................................................................................... 42 
11.2  Certificate of Confidentiality  ...................................................................................................... 42 
11.3  Risks and Benefits  ...................................................................................................................... 43 
11.4  Institutional Review Board (IRB) Review and Informed Consent  ............................................. 45 
11.5  Waiver of the Requirement for Signed Consent Form  ............................................................... 46 
11.6  Prisoner Participation  ................................................................................................................. 46 
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 5 of 52 11.7  45 CFR Parts 160 and 164 Standards for Privacy of Individually Identifiable Health 
Information ("Privacy Rule" Pursuant to the Health Insurance Portability and Accountability 
Act -  HIPAA)  .............................................................................................................................. 47 
11.8  Study Discontinuation  ................................................................................................................ 47 
12.0 PUBLICATION OF RESEARCH FINDINGS  ...................................................................... 47 
13.0 REFERENCES  ....................................................................................................................... 48 
 
 
 
  
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 6 of 52 PROTOCOL TEAM ROSTER  
Jesse  Golinkoff , MPH  
Research Project Manager  
University of Pennsylvania School of Nursing 
418 Curie Blvd, Room 239L 
Philadelphia, PA 19104  
215-898-0570  
agolinko@nursing.upenn.edu  
 
Keith Horvath, PhD  
Co-Investigator  
University of Minnesota School of Public Health  
1300 South Second Street, #300  
Minneapolis MN 55454  
612-626-1799  
khorvath@umn.edu  
 
Nadia Dowshen, MD  
Co-Investigator  
The Children’s Hospital of Philadelphia 
3535 Market St, Room 1542 
Philadelphia, PA 19104  
215-590-3749  
dowshenn@email.chop.edu  
 
Anderson Schlupp, BS  
Clinical Research Assistant  
The Children’s Hospital of Philadelphia 
3535 Market St, Suite 1371 
Philadelphia PA 19104  
215-370-6446   
schluppa@email.chop.edu   
 Bevin Gwiazdowski, MSW  
Clinical Research Coordinator  
The Children’s Hospital of Philadelphia  
3535 Market St , Suite 1370 
Philadelphia PA 19104 267-426-9281  
gwiazdowsb@email.chop.edu
  
 Mary E. Paul, MD  
Site PI  
Texas Children’s Hospital  1102 Bates S t, Suite 630  
Houston, Texas 77030  
832-824-1143  
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 7 of 52 mepaul@texaschildrens.org   
 
PRIMARY SITE CONTACT FOR PROTOCOL  
 
 
Philadelphia  
 
Jesse  Golinkoff, MPH  
Research Project Manager  
University of Pennsylvania School of Nursing 
418 Curie Blvd, Room 239L 
Philadelphia, PA 19104  
215-898-0570  
agolinko@nursing.upenn.edu  
 
 
Atlanta  
 
Mondie Tharp, MPH  
Associate Director of Programs  
Emory University  
Rollins School of Public Health 1518 Clifton Road NE  
Atlanta GA, 30322  
404-712-2224  
Mondie.b.tharp@emory.edu
 
  
Houston 
 
Dalisa Santiago  
Study Coordinator  
Texas Children’s Hospital  
1102 Bates S t, Suite 630  
Houston, Texas 77030  
832-824-1143  
dxsantia@texaschildrens.org
  
 
ATN 139 -  Get Connected!   Version 2. 3_14-Dec-2018  
 
Page 8 of 52  
 LIST OF ABBREVIATION S AND DEFINITION OF TERMS  
 
AC   Analytic Core  
AIDS    Acquired Immunodeficiency Syndrome 
ART   Antiretroviral Therapy  
ASO    AIDS Service Organization 
ATN   Adolescent Medicine Trials Network for HIV/AIDS Interventions  
CASI    Computer Assisted Self Interview  
CDC    Centers for Disease Control and Prevention 
CFR   Code of Federal Regulations  
CRF   Case Report Form 
DCF   Data Collection Form 
DHHS    U.S. Department of Health and Human Services  
EC   Ethics Committee  
GC   Get Connected  
GCP    Good Clinical Practices  
HIPAA   Health Insurance Portability and Accountability Act  
HIV   Human Immunodeficiency Virus  
ICH   International Conference on Harmonization 
IRB   Institutional Review Board 
LGBTQ   Lesbian, Gay, Bisexual, Transgender, Queer  
MC   Management Core  
MTS    Michigan Tailoring System, a platform for eHealth interventions  
NICHD   National Institute of Child Health and Development  
NIDA    National Institute on Drug Abuse  
NIH   National Institutes of Health 
NSDUH   National Survey on Drug Use and Health  
OHRP    Office for Human Research Protections  
PI   Principal Investigator  
PrEP   Pre-Exposure Prophylaxis  
QNS    Query and Notification System  
RDC    Remote Data C apture  
SRV   Subject Recruitment Venue 
STI   Sexually Transmitted Infection 
TC   Technology Core  
YMSM    Young Men who have Sex with Men  
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 9 of 52 STUDY ABSTRACT  
 
DESIGN:  A two-arm prospective randomized controlled trial ( RCT) 
in Philadelphia, Houston, and Atlanta. Participants 
randomized to the control condition will only see the site 
locator portion of the Get Connected intervention website. 
It will include information on HIV prevention services.  
Participants randomized to the intervention condition will 
receive tailored online content specific to their  
demographic characteristics (e.g., age, race/ethnicity, location, and relationship status), HIV/STI risk behaviors 
(e.g., HIV/STI testing history; substance use; 
communication with partners regarding status) and 
sociocultural context (e.g.,homelessness, i ncarceration).  
We will also recruit , enroll,  and train 10-15 mystery 
shoppers per city to conduct a mystery shopper 
assessment. Two mystery  shoppers will visit each testing 
site separately and complete a standardized assessment 
of their visit.  Site directo rs from 10 randomly selected 
testing sites in each city will be interviewed t o assess 
sites’ satisfaction with the biannual  performance 
assessments and their improvements in service delivery 
when working with YMSM . 
  
DURATION:  Mystery shoppers are enrolled for approximately six 
months, or the time it takes them to complete approximately ten site visits. YMSM participating in the 
RCT are enrolled for 12 months . 
  
SAMPLE SIZE:  Total study sample size  is 480 with the aim of maint aining 
a randomized sample of approximately 400 online -
recruited and retained YMSM for 12 months. After 
consent , but prior to completion of the baseline survey, 
YMSM are randomized to either the intervention (n=240) 
or control (n=240) condition.  
  
POPULATION:  Individuals who were assigned male at birth and currently 
identify as male. 15 -24 year -old (inclusive ), self-report as 
HIV-negative or sero -status unaware, speak and read 
English, live in Philadelphia, Houston, or Atlanta, and  
meet one or bot h of the following high risk criteria: have 
not received HIV testing in past six month s and/or  report 
having consensual anal sex with a man in the past six 
months.   
  
STRATIFICATION:  Each site  (Houston, Atlanta, and Philadelphia)  will enroll 
160 YMSM  and 10-15 mystery shoppers .  
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 10 of 52   
  
DATA  
COLLECTION:  For study participants, w e will use SurveyGizmo to collect 
YMSM’s data. Online surveys allow participants to 
complete the survey at a convenient location, circumvent 
barriers (e.g., scheduling, transportation) and decrease 
social desirability. Participants may complete surveys on 
a mobile device  or desktop or laptop computer on which 
they feel comfortable, or they may visit the s ubject  
recruitment venue  (SRV) . At baseline, participants will be 
logged into the SurveyGizmo assessment by site study 
staff. For follow -up assessments, participants will rec eive 
a unique link which will allow them to complete the 
survey s in multiple sittings or to resume a survey that has 
timed out or been closed.  Mystery shoppers will use 
Qualtrics to complete an evaluation of each visited site. 
Interviews with agency directors will be audio- recorded to 
allow for verbatim transcription of the interview and 
checked for accuracy and completion.  
 
  
OBJECTIVES  To test the efficacy of an e -Health intervention for 
increasing HIV -negative or HIV -unknown YMSM’s 
successful upt ake of HIV a nd STI testing willingness   (e.g., 
routine HIV/STI testing) and PrEP awareness and 
willingness, as compared to the attention- control condition 
over a 12- month period.  
To examine the quality of HIV test counseling and PrEP -
related referrals to YMSM within local HIV/STI testing sites 
in 3 cities (Houston, Philadelphia, and Atlanta) through the 
use of mystery shoppers  
Qualitatively assess testing sites’ satisfaction with the 
biannual  performance assessments and their 
improvements in service delivery when working with 
YMSM across the three regions.  
 
 
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 11 of 52 Study Design or Schema  
 
 
 
 
 
 
Per the diagram above, the study is a tw o-arm randomized control led trial. Once participants 
are proven eligible and they have provided informed consent, they will be randomized to one 
of two arms: intervention (Get Connected) and control  (site locator portion of Get 
Connected). Participants randomized to the control condition will only have access to the site locator portion of Get Connected, with information on HIV prevention services. 
Participants randomized to the intervention condition will receive tailored online content 
specific to their demographic characteristics (e.g., age, race/ethnicity, location, and 
relationship status), HIV/STI risk behaviors (e.g., HIV/STI testing history; substance use; 
communication with partners regarding  status) , and sociocultural context (e.g., 
homelessness, incarceration). Five study assessments (surveys) are conducted at months 
1, 3, 6, 9 , and 12 for a total of 12 months follow -up for each arm. 

ATN 139 -  Get Connected!   Version 2. 3_14-Dec-2018  
 
Page 12 of 52  
 1.0 INTRODUCTION 
 
1.1  Background  
In 2010, young men who have sex with men (YMSM) (aged 13- 24) accounted for 30% of all 
new HIV infections among men who have sex with men (MSM)1,2. The HIV epidemic among 
YMSM is characterized by strong racial disparities; recent NHBS (Na tional HIV Behavioral 
Surveillance) analysis showed 26% of African American MSM youth (18- 24 years) tested HIV 
positive, compared to only 3% of White MSM 18- 24 year olds3. STI infections are also known to 
increase risk for HIV acquisition. With increasingly promising evidence of the efficacy of 
biomedical prevention tools, such as PrEP, for reducing risk of HIV infection among MSM4-9, 
there is increased attention to the potential for HIV testing to act as a gateway to other HIV 
prevention tools and care efforts3,10. Many of t he cognitive and behavioral risk factors that 
contribute to the high rates of HIV infection among MSM are established during adolescence 
and the transition into young adulthood. This age group should be considered a priority time for 
intervening on cogniti ve and behavioral risks for HIV, while also introducing YMSM to HIV  and 
STI testing as a gateway to other HIV prevention options. However, successful adoption of HIV 
prevention tools requires that YMSM overcome a series of multi -level barriers at the individual 
(e.g., risk awareness), systems (e.g., costs, lack of culturally competent care), and structural 
(e.g., homelessness, stigma) levels. Therefore, developing strategies to promote the use of HIV 
prevention services among YMSM requires the creation of interventions that are culturally 
sensitive to their psychosocial needs11 and facilitate access to comprehensive sexual health 
services12. 
 
1.2  Rationale  
There is strong evidence of a significant and growing HIV epidemic among YMSM1. From 2008–
2011, YMSM aged 13– 24 years had the greatest percentage increase (26%) i n diagnosed HIV 
infections2, with approximately 93% of all diagnosed HIV infections from male- to-male sexual 
contact2. The HIV epidemic among YMSM is characterized by strong racial disparities. In an 
analysis of NHBS data from 2008 -2014, Wejnert et al3 demonstrated that black MSM did not 
report greater sexual risks than other MSM, but were most likely to be infected with HIV and 
least likely to know it. Among black MSM aged 18– 24 years tested in 2014, 26% were HIV 
positive, yet among white MSM aged 18– 24 years tested in 2014, 3% were HIV positive. The 
disparity in HIV prevalence between black and white MSM increased from 2008 to 2014, especially among YMSM.  YMSM now account for 72% of new infections among people ages 13 
to 24, and 30% of all new infections among MSM
20. HIV prevention tools are needed that can 
address the unique developmentally specific prevention needs of YMSM, and that are culturally and developmentally adapted for this population in transition
13-16. Even if they were 
developmentally adapted, however, most of the existing evidence- based interventions (EBIs) for 
MSM (e.g., Many Men, Many Voices; MPowerment; d- up!) are delivered in face -to-face group 
settings. This creates a paradox: for many youth perceived or anticipated stigma, concerns over revelations of sexual or gender identity , and a lack of economic resources create barriers to 
YMSM attending the very interventions that are intended to reduce these barriers
17. Hence, 
online delivered interventions may have a significant advantage for this population, particularly 
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 13 of 52 given that YMSM may not be able to access in- person EBIs in their communities, to attend 
sessions when they are offered, and to engage with the interventions’ content when most 
convenient and appropriate18,19.  
 A review of CDC’s list of EBIs shows several interventions with efficacy for high -risk youth. 
Among these, Assisting in Rehabilitating Kids (ARK), Focus On Youth (FOY), Becoming a 
Respons ible Teen (BART), iCuidate! (Take Care of Yourself) and Be Proud! Be Responsible are 
all group delivered interventions, requiring youth to be physical and economically able to attend 
a group setting, and comfortable with discussing sensitive issues in groups of their peers. The 
only one- on-one intervention for YMSM classified as an EBI is Choosing Life: Empowerment, 
Actions and Results (CLEAR), but this is specific to improving ART adherence among YMSM 
living with HIV. Absent from the list of youth- focused EBIs is an online intervention for YMSM 
that surmounts the barriers associated with attending HIV services, and focuses on creating shifts in cognitive and behavioral HIV -related outcomes for YMSM. If proven efficacious, the 
proposed intervention –  Get Connected  – can fill this gap by providing an e- delivered, tailored 
intervention that allows YMSM to learn about local prevention services and build the skills 
necessary for successful adoption of prevention.  
 
1.2.1  Repeat HIV/STI testing has the potential to reduce HIV testing by increasing knowledge 
of sero -status and act as a gateway to other prevention options  
In light of the high incidence of HIV among YMSM, creating behavioral shifts towards routine 
HIV testing must be considered a priority goal.  Among the drivers of the HIV epidemic among 
YMSM are large numbers of HIV positive youth who are not virally suppressed and/ or are not 
aware of their sero- status. Increasing HIV testing among YMSM should thus be considered a 
public health priority
20. The success of the National HIV/AIDS Strategy’s test and treat approach 
rests on the ability to increase the number of YMSM who receive routine testing. Getting tested 
is the cornerstone of almost all prevention approaches and the gateway to both biomedical 
preventions tools (e.g. , PrEP) and to HIV care for those who test positive. Successful 
engagement in HIV prevention for HIV negative youth (routine HIV testing, consistent condom 
use, PrEP adoption) and care services for HIV positive youth (e.g., linkage and retention in care; 
access to ART to promote viral suppression) requires that YMSM overcome a series of multi -
level barriers at the  individual (e.g., risk awareness, self -efficacy to get tested), systems (e.g., 
costs, medical mistrust, lack of culturally competent care), and structural (e.g., homelessness, 
costs, stigma) levels17,21 -26.Therefore, developing strategies to promote HIV/STI status 
awareness among YMSM requires the creation of interventions that are culturally sensitive to the psychosocial needs of YMSM
11 and facilitate access to comprehensive sexual health 
services12. In response to these challenges, our intervention recognizes that it is important to 
activate our target population’s awareness of  their increased risk and readiness to learn about 
prevention strategies prior to linking them to services.  
 
1.2.2  Online delivered HIV prevention interventions are ideal to reach and engage YMSM in 
conversations about their HIV risks  
Given youths’ increas ed use of online media in their day -to-day exchanges, online  interventions 
have numerous advantages over in- person delivered interventions. Online interventions are a 
promising mode of HIV/STI prevention given their ability to deliver responsive and interactive 
content specific to each user’s characteristics (i.e.,  tailored content), with extended reach across 
geographic regions and increased convenience to access content at any time through tablets, 
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 14 of 52 laptops, and smartphones. Furthermore, online content can be refreshed to be contextually -
responsive over time, parti cularly as YMSM become sexually -active, meet new partners and/or 
engage in different risk behaviors. Delivery of online content may also ensure higher 
intervention fidelity and may be accessed through smartphones if YMSM are unable to afford 
internet -based connectivity due to socioeconomic barriers. Data from the 2015 Pew Teens & 
Technology Surveys27, noted that 92% of teens go online daily. Internet use27 among youth in 
the U.S. was near 97% in 2014, with more than 70% of youth having broadband at home and/or connecting via a mobile device. Although Whites (91%) are more likely than Blacks or Latinos to 
report owning a desktop or laptop computer (~80% each), Black teens are more likely to own a smartphone (85%) and go online through a mobile device (100%) than Whites (71% ownership, 
90% access). Collocating online interventions is also important as YMSM often rank the web as 
their top resource to access comprehensive sexual education, learn about their sexuality and 
sexual behavior, and meet partners
18. 
 
1.2.3  Test locators are becoming increasingly popular as a means of linkage to care  
Researchers and practitioners have sought to encourage timely and repeated HIV/STI testing by creating online tools that provide the location of testing centers in a given geographic area 
(i.e., test locators). These testing locator interventions have demonstrated wide reach when 
evaluated (e.g., AIDS.gov test locator had over 16,000 searches and was adopted by over 100 
websites in its first year
28); however, there are no peer -reviewed published data examining the 
appeal of these locators within YMSM populations specifically or the qual ity and adequacy of 
these listed sites for YMSM . This is concerning for several reasons. First, it is expected that 
testing agencies are youth and LGBTQ (i.e., lesbian, gay, bisexual, transgender and/or queer) friendly, but there is little empirical evidence to support this assumption, and in fact evidence to 
support the contrary
21,29 -33. Second, our efforts to encourage and motivate YMSM to engage in 
repeat HIV/STI testing or to adopt other prevention efforts (e.g. PrEP4-6) may be diminished if 
structural barriers (e.g., medical mistrust, lack of insurance or transportation) and cultur al 
insensitivity to YMSM’s needs (e.g., racial/ethnic and sexual orientation stigma) lead to delays 
or avoidance of HIV/STI services24,34,35. The GC intervention seeks to address these systemic 
challenges by providing a test locator that accounts for sites’ quality of HIV prevention service 
delivery and their ability to cater to YMSM’s needs.  
 
Building on the efficacy of the CDC’s Project Connect Health Systems Intervent ion to link 
heterosexual adolescents to competent comprehensive sexual health care services36, we 
developed Get Connected (GC), an online brief intervention that employs individual and 
systems- level tailoring technology to reduce barriers to HIV prevention care (e.g., HIV/STI 
testing, PrEP) for YMSM. The deployment of GC through a mobile- friendly WebApp seeks to 
optimize onl ine interventions’ acceptability, accessibility, availability, and long- term affordability 
among youth19,37,38. GC was developed for YMSM (ages 15 -24) through a community -based 
participatory research approach that included a rapid assessment of existing HIV services 
through a mystery shopper methodology21, and the creative input of scientists, service 
providers, and YMSM . Data39 from our pilot RCT (N=130 YMSM; ages 15- 24) indicated high 
acceptability and feasibility for GC, and clinically meaningful effect sizes (ES) in self -efficacy to 
discuss HIV testing with partners  (ES=.50 -.64), trust in their providers (ES= .33- .35), reduct ions 
in number of sexual partners (ES=.21), and HIV/STI testing behavior (ES=.34; 30% of 
participants tested for HIV/STIs) at the 30 -day post -intervention follow -up.  
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 15 of 52 2.0 STUDY OBJECTIVES  
As part of the U19 project, we propose to test the efficacy of Get Connected (GC) for  increasing 
HIV-negative or sero -status unaware YMSM’s successful uptake of HIV and STI testing 
willingness  (HIV and STI testing). Given the overall low level of PrEP awareness and use 
among YMSM currently4-6,40, we also include awareness of and willingness to use PrEP as a 
primary outcome (PrEP u ptake during the trial will be measured as a secondary outcome). At 
the agency level, HIV/STI testing sites listed in GC will receive biannual  performance 
assessments based on ratings that YMSM provide after visiting their locations. We will examine 
improvements in the quality of HIV test counseling and PrEP -related referrals to YMSM 
accessing local HIV/STI testing sites in the 3 cities selected to test GC.  
 
2.1  Primary Objective:    
Test the efficacy of GC for increasing HIV -negative  or HIV -unknown YMSM’s successful 
uptake of HIV and STI testing (e.g., routine HIV/STI testing) and increase in PrEP 
awareness and willingness, as compared to the attention- control condition over a 12-
month period.  
 
2.2  Secondary Objective:    
Examine the quality of HIV test counseling and PrEP -related referrals to YMSM within 
local HIV/STI testing sites in 3 cities (Houston, Philadelphia, and Atlanta) through the use 
of mystery  shoppers . 
 
2.3  Tertiary  Objective:    
Qualitatively assess testing sites’ satisfaction with the biannual  performance assessments 
and their improvements in service delivery when working with YMSM across the three 
regions.  
 
2.4  Study Hypotheses/Research Questions   
• Relative to the control condition, YMSM exposed to the GC intervention will report 
significantly greater increases in routine HIV/STI testing over a 12 -month period.  HIV 
testing will be the primary outcome for the trial.  
• Relative to the control condition,  YMSM exposed to the GC intervention will report 
increases in motivation around HIV  testing (conceptualized as HIV/STI testing intentions, 
self-efficacy to engage in HIV /STI testing,  and overcoming testing- related barriers) . 
• Relative to the control conditi on, YMSM exposed to the GC intervention will report 
significantly greater  PrEP awareness and willingness  to use PrEP ). 
 
The primary analyses of the data from the Get Connected 2 -parallel group randomized clinical 
trial will be performed according to the participants’ original treatment assignment (i.e., intention-
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 16 of 52 to-treat analyses) and the inclusion of all data from all participants randomized in the final 
analysis.  
 
Binary outcomes such as HIV testing:  
 
The percentage of participants who report routine HIV testing over a 12- month period will be 
compared between the interventions arms (GC and the Control condition). Five assessments 
will occur at 1 month (visit window ± 1 month), 3 months (± 1 month), 6 months (± 1 month) ,9 
months (± 1 month), and 12 months (± 1month).  Repeated-  measures analyses for HIV testing  
will be implemented by performing a generalized estimating equations (GEE) analysis via the SAS GENMOD Procedure (version 9.4; SAS Institute, Cary, NC)  with an exchangeable 
correlation structure for the repeated measures within participant (binomial -logit model).  The 
statistical model will include three predictors (intervention arm, time on study and the statistical interaction between intervention arm and time on study).   The statistical model will provide 
estimates of the percentages of participants reporting HIV testing (plus 95% confidence intervals) by intervention arm and time on study. The model -based estimates are unbiased with 
unbalanced and missing data, so long as the missing data are non -informative (missing 
completely at random, MCAR). A P value ≤0.05 will be considered statistically significant for the main effects (intervention and time on study) and for the intervention by time on study 
interaction effect fr om the repeated measures analysis.  The statistical test for interaction 
between time on study and intervention arm will be the primary overall hypothesis test to 
determine whether HIV testing in the intervention groups changed in significantly 
different ways during follow -up (i.e., different temporal patterns over time).   If HIV testing 
rates in the two intervention groups are consistently different or similar (i.e., no statistical 
interaction) then the main effect test for intervention will be used as the primary test of 
intervention efficacy. If a significant interaction is detected, then Wald chi -square tests will be 
used to compare the differences between the model -based HIV testing estimates at each time 
interval and to compare differences over time wit hin each intervention arm. Specific statistical 
tests will be done within the framework of the generalized linear model. All statistical tests will be 2- sided and unadjusted for multiple comparisons.   
 The primary assessment for a difference between inter vention arms for ‘frequent tester’ rates will 
be a two- sided Z -test for independent proportions with pooled variance. Confidence intervals 
(95%) will also be reported for the observed difference between the GC and control arms in ‘frequent tester’ rates. T he same analysis plan described above will be used for the other primary 
outcomes that as binary (i.e., STI testing, PrEP awareness).  
 
 
Continuous outcomes such as Self -efficacy:  
 
Repeated- measures analyses for self -efficacy will be performed with a means model via the 
SAS MIXED Procedure (version 9.4; SAS Institute, Cary, NC) , providing separate estimates of 
the means by time on study (at 5 scheduled assessments) and intervention group.  The model 
will include three predictors (intervention arm, time on study and the statistical interaction 
between intervention arm and time on  study).  A compound- symmetric variance -covariance 
form in repeated measurements will be assumed for self -efficacy  and robust estimates of the 
standard errors of parameters will be used to perform statistical tests and construct 95% 
confidence intervals
76. The model -based means are unbiased with unbalanced and missing 
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 17 of 52 data, so long as the missing data are non -informative (missing at random, MAR).  A P value 
≤0.05 will be considered statistically significant for the main effects (intervention and time on 
study) and for the intervention by time on study interaction effect from the repeated measures 
analysis.  The statistical test for interaction between time on study and intervention will be 
the primary overall hypothesis test to determine whether self -efficacy  in the two 
intervention groups changed in significantly different ways during follow -up (i.e., 
different temporal patterns over time) .  If mean self -efficacy in the two intervention groups is 
consistently different or similar over time (i.e., no statistic al interaction) then the main effect test 
for intervention will be used as the primary test of intervention efficacy.  If a significant interaction is detected then t -tests will be used to compare the differences between the model -
based intervention means at each time point and to compare differences over time within each 
intervention arm.  Specific statistical tests will be done within the framework of the mixed effects linear model. All statistical tests will be 2 -sided and unadjusted for multiple compari sons.  The 
same analysis plan described above will be used for the other outcomes that are continuous (i.e., willingness to use PrEP).  
 
3.0 STUDY DESIGN  
3.1 Study Phases  
In this four -year study, we will enroll 480 self -reported HIV -negative or sero -status unaw are, 
sexually active YMSM (ages 15- 24) across three sites and randomize them into the GC 
intervention condition or to an attention- control condition. Primary outcomes will include (1) use 
of HIV prevention services (HIV testing, STI testing) and PrEP awareness and willingness. As 
secondary outcomes, we will assess PrEP use, sexual risk behaviors, and the linkage and 
retention in care among newly diagnosed HIV+ cases. We will also examine changes in GC’s 
theorized mechanisms of change, including YMSM’s attit udes, norms, self -efficacy , and 
behavioral intentions to adopt HIV prevention services.  
 
Control condition:   Participants randomized to the control condition will have access to the site 
locator portion of the Get Connected website, which includes information on HIV prevention services.  While the provision of a test locator is a form (albeit weak) of an intervention, we felt 
that withholding referrals to testing and care services would be unethical given YMSM’s 
vulnerability to HIV and STIs. Further more, given the availability of search engines to locate 
HIV/STI testing sites, the test locator condition may be considered usual care. Nevertheless, by providing the testing site locator only, we will be able to test the effect of the GC intervention 
condition (i.e., user -tailored content focused on HIV/STI testing and PrEP referral and the 
linkage to high- quality agencies)  against the usual care control condition .  
 
Intervention condition:   Using a consensus approach41 to conceptualize health behavior change, 
the model guiding GC synthesizes The Integrated Behavioral Model42 and Self -Determination 
Theory43,44 as the theoretical underpinnings of our intervention. These theories emphasize 
social cognitive factors that impact behavior change and have informed HIV interventions45-48. 
Consistent with these theories49,50, GC content follows motivational interviewing (MI) 
principles46,50,51 by focusing on resolving ambivalence about HIV prevention behaviors, 
increasing self -efficacy for change, and enhancing motivation moving toward action. The 
intervention was developed by c ustomizing content based on YMSM’s psychosocial and sexual 
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 18 of 52 profile (e.g., socio -demographics, HIV/STI testing history and testing motivations, recent sexual 
behavior, sources of support, self -reported values), as reported by participants’ answers to their 
baseline assessment . At the individual -level, GC delivers tailored online content specific to each 
user’s demographic characteristics (e.g., age, race/ethnicity, location, relationship status), 
HIV/STI risk behaviors (e.g., HIV/STI testing history; substance use; communication with 
partners regarding status) and sociocultural context (e.g., homelessness, incarceration) . GC 
also employs tailoring at the systems -level. Participants across both conditions who report being  
tested since their last follow -up survey will be asked to complete a site assessment as part of 
their follow -up survey . Testing sites will receive biannual performance summaries that include 
aggregated participant scores from the site assessments, qualitative feedback participants 
provided, and their sites’ scores in relation to other testing sites in their city. These summaries 
are provided in an effort to help sites understand their performance based on quality assurance 
evaluations from YMSM clients and to optimize service delivery if needed . The study team and 
Analytic Core will ensure that these summaries will not include any identifying information about participants.  
 Increasing Awareness :   
The first section of the GC tailored website exhibits the “What” of HIV and STI testing. The first 
subsection, “The Facts,” presents a grid of STI facts in a random order. The final box is a list of 
seven questions participants can ask a provider during a testing visit. These questions were developed by the GC youth and community advisory boards, and were found to be helpful to 
pilot trial participants when they encountered test counselors who weren’t perceived to be 
effective. The second subsection, “STIs,” displays boxes that contain the names of specific STIs. Once clicked, pop- up content presen ts information specific to that STI including what kind 
of infection it is, how it can be contracted, possible symptoms, testing options (e.g., oral swab 
versus blood draw), and treatment options (if applicable). The third subsection “Tests,” displays 
boxes with information on the different types of tests for STIs (e.g. , blood test, saliva test, swab 
test). Once clicked, pop -up content presents information on what STIs each type of test can test 
for, and the specific steps taken to administer the test  and contains general prevention facts 
(e.g.,  “You won’t always know if someone has an STI.”) relevant to this population.  
 
Promoting self -appraisal and increasing motivation for engaging in prevention services:  The 
second section of the GC tailored website, the “Why,” encourages participants to assess their 
motivations, values, and strengths regarding HIV/STI testing. Reasons for getting tested are 
tailored to participants’ testing history (e.g., “Never tested” versus “Tested for HIV, but not STIs”) 
in order to acknowledge their prior behaviors. Building on best practices, persuasive messages 
regarding the importance of linking to prevention services are presented by linking participants’ 
values to the desired outcomes. GC then reinforces behavioral (e.g., hav ing tested between 
follow -up assessments) and cognitive aspects of HIV prevention services that participants 
expressed confidence in doing (e.g., asking a partner to get tested before having sex) based on 
baseline or follow -up assessments.  
 
Acknowledging and Overcoming Barriers:  The third section of the GC tailored website, the 
“How,” explores barriers (e.g., financial costs, social norms, and prioritization) to participants’ 
desire to get tested for HIV/STIs, as well as how their strengths and social support systems can 
help them make a choice about testing. Recognizing that barriers and supports may shift over 
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 19 of 52 time, the pages’ content is tailored based on the most recent responses to questions in the 
follow -up assessments. This way, GC can address current  barriers, provide strategies on how to 
overcome them, and current supports, with suggestions for how to utilize them.  
 
Linking Users to Culturally -Sensitive Providers:    
The final section of the GC tailored website, the “Where,” contains a listing of local testing sites 
and filtering options (e.g. , visit can be 30 minutes or less, site is open on weekends, site 
prescribes PrEP). Testing sites are rank -ordered using an algorithm that accounts for each 
site’s average mystery shopping scores regarding the site’s LGBTQ inclusivity and 
confidentiality during the testing process, providers’ LGBTQ friendliness, discussion of sex and 
relationship goals, ability to discuss motivations for testing, sex positive tone, avoidance of 
making assumptions about the client, assessment of potential intimate partner violence, and 
pressure to adopt risk reduction strategies. Participants can choose to send specific site 
information to themselves via email or text message.  
 
 Primary objective:  
 
• Phase 1a : Populating the Sites  
We will create a master list of the HIV/STI tes ting sites and employ our mystery  shopper 
methodology to examine the quality of HIV test counseling and local HIV/STI testing 
sites in the 3 trial cities (Houston, Philadelphia, and Atlanta) . Data will then be entered 
into our existing GC test locator console.  During the first 3 months of the project , we will 
train research assistants to identify existing HIV/STI locations and PrEP providers across the three cities. Following a sequential method, research assistants will compile an 
exhaustive list using  the local health department HIV testing site directory . They will then 
triangulate the information obtained through CDC’s National Prevention Information 
Network ( NPIN)  with HIV/STI testing and PrEP providing locations using Google search. 
Emory has collected a list of PrEP provider r egistries already and worked with NASTAD 
(National Alliance of State and Territorial AIDS Directors) , Kaiser Family Foundation and 
UCSF (University of California, San Francisco) to launch a national provider registry in 
summer 2016, which is  available and updated as necessary for this project. We will then 
verify the information obtained by calling the clinics and verifying their HIV/STI testing 
hours, services provided, phone numbers, addresses, language used to describe clients 
and services, targeted client age, and cost of services. Once this information is 
reconciled, sites’ information will be entered into the open- source GC console. Agency 
characteristics are used to sort sites based on their geographic area, operating hours, ability to test without an appointment, proximity to public transportation, and insurance or 
ID requirements.  
 
• Phase 1b: Recruitment  and eligibility  for RCT  
Using 2014 American Community Survey data about the racial/ethnic distribution of 
children under the age of 18, we propose to sample a racially/ethnically diverse sample 
of YMSM that parallels the racial/et hnic distribution in each city. We will use 
geographically targeted ads on sites including Facebook, Tumblr, Instagram, Reddit , and 
Twitter.  
 
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 20 of 52 • Phase 1c: Data  Collection and Retention  for RCT  
We will use  SurveyGizmo  to collect YMSM’s data. At baseline, participants will be 
logged into the SurveyGizmo assessment by site study staff. For follow -up assessments, 
participants will receive a unique link which will allow them to complete the surveys in 
multiple sittings or to resume a survey that has timed out or been closed.  Online surveys 
allow participants to complete the survey at a convenient location, circumvent barriers 
(e.g., scheduling, trans portation) present in interviewer -administered or phone- based 
interviews, and decrease social desirability. To maximize completion rates , participants 
will receive email and/or text reminders  that a survey is available . Although we will 
employ recommended strategies to avoid loss to follow -up, we project a conservative 
attrition of 20%. In the pilot study, we achieved >80% retention using the approaches proposed here.  
 
 
Secondary  objective:  
 
• Phase 2a: Enrolling  and Training of Mystery Shoppers 
We will enroll  and train 10-15 mystery shoppers per city  to conduct the mystery  shopper 
assessment s. This approach follows best practices indicating that youth involvement is 
vital when designing relevant and appropriate HIV interventions for the target population. As study staff, w e will work with the AT N site in each city to enroll  HIV-negative YMSM 
(ages 18 -24) who are interested in serving as mystery shoppers. We will employ a 
stratified purposive sampling strategy to ensure age and racial/ethnic diversity across 
mystery shoppers. Of the 10- 15 mystery shoppers  in each city , we will attempt to recruit 
diversity in age and race/ethnicity. Mystery shoppers will be 18 to 24 years old (inclusive).  
 
• Phase 2b: Site Visits  
Based on feedback from agency directors in our original study, we will send all agency directors a letter infor ming them of their site’s selection for the study before the mystery  
shopper visits and contact information to reach the research PIs if they have questions 
about the procedures. Shoppers will be instructed to report that they do not have income or health insurance and do not possess any proof of identification. In so doing, we will be 
able to ascertain whether these would be potent ial barriers to testing at a given location 
and determine the lowest possible fees that would be charged to a YMSM.  
 
• Phase 2c: Integration of Scores into GC Console  
We will enter the 10 domain scores from the mystery shopping evaluations for each site into our GC administrative console, hosted online,  and accessible to the study team for 
maintenance (e.g., if a testing location changes its hours of operation or closes). The rating criteria are not meant to establish an absolute measure of each site, but rather a 
rating that may then be used relative to an individual’s stated needs and desires for his 
testing experience. An average between the composite site score and the user’s stated 
values will be used to rank a provided list of local HIV/STI testing sites.  
 Tertiary  objective:  
 
• Phase 3a: Randomly Select 10 Sites from E ach City 
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 21 of 52 We will randomly select 10 sites from  Philadelphia, Houston, and Atlanta to carry  out 
semi -structured qualitative in- depth interviews with the agency’s director . 
 
Eligibility Criteria for Site Directors:   
o Speak and read English  
o Site director of an HIV/STI testing site  
o The testing site is located in Philadelphia, Atlanta, or Houston  
 
• Phase 3b: In -Depth  Interviews 
The interviews (60- 90 minutes) will focus on 4 domains: (1) existing prevention services 
used and/or promoted by the agency, (2) agency (internal) resources currently missing, 
that if identified and addressed, could improve delivery of HIV/STI and PrEP services to 
YMSM, (3) feedback on the biannual  evaluation assessments and their use for service-
delivery improvements, and (4) the advantages and disadvantages of GC rollout within 
ASOs. We will interview providers via teleconference in a private office at the University 
of Pennsylvania to maximize candidness and privacy while decreasing travel -related 
costs. We will use BlueJeans , a simple and low cost alternative that requires no server 
infrastructure to set up or maintain and allows providers to be HIPAA -compliant . 
University of Pennsylvania holds the BAA for this BlueJeans license.  The site directors 
will not be compensated for their participation in these interviews.  
 
3.2  Study Population  
For the primary objective, w e plan to recruit a diverse sample of 15 -24 year olds. Of the 480 
participants, we propose that 98 (20%) will be non- Hispanic white men, 232 (48%) will be non-
Hispanic black men, 122 (25%) will be Latino men, 22 (5%) will be non- Hispanic Asian -Pacific 
Islanders, and 6 (2%) will be other non -Hispanic or  multi- racial men. Transgender participants 
are excluded in this protocol as the intervention has not been adapted to meet the needs of 
transgender youth.  
 
Eligibility criteria will include the following :  Individuals who were assigned male at birth and 
currently identify as male , 15-24 year s old (inclusive), self -report as HIV -negative or sero -status 
unaware, speak and read English, live in Philadelphia, Houston, or Atlanta, and meet one or 
both of the following high risk criteria: have not received HIV testing in past six months and/or 
report having consensual anal sex with a man in the past six months.  
 
For the secondary objective, we plan to recruit a diverse group of 10 -15 mystery shoppers per 
city. Mystery shoppers will be 18 to 24 years old (inclusive).  
 
Eligibility criteria will include the following:  Individuals who were assigned male at birth and 
currently identify as male, 18 -24 years old (inclusive)  at time of screening, self -report as HIV -
negative, speak and read English, live in Philadelphia, Houston, or Atlanta, are able to travel to 
and from HIV/STI testing sites, report same- sex attraction, and have access to internet via a 
computer or smartphone . 
 
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 22 of 52 For the tertiary objective, w e will randomly select 10 testing sites per city who participated in the 
mystery shopper perspective and conduct a  semi -structured qualitative in- depth interview with 
the site’s  director.  
 
Eligibility criteria will include the following : Individuals who ar e site director s of an HIV/STI 
testing site  in Philadelphia, Atlanta, or Houston, and who can s peak and read English.  
 
 
3.3 Sample Size  
For the primary objective, t he research activities involve enrolling a sample of 480 HIV negative 
or status unaware YMSM  (15-24 years ), with the aim of maintaining a randomized sample of 
approximately 400 online- recruited YMSM over 12- months.  
 
For the secondary objective, the research activities involve enrolling a sample of 30-45 HIV 
negative YMSM (18- 24 years), with the aim of visiting each city’s public testing sites twice  - two 
mystery shoppers will visit each testing site (i.e., the same shopper will not go to the same testing 
site twice).  
For the tertiary objective, the research activities involve enrolling a sample of 10  HIV testing  site 
directors per city , with the aim of conducting a semi -structured qualitative in- depth interview.  
3.4 Study Randomization, Stratification, or Description of Non -Random Assignment 
Procedures  
For the primary objective, participants will be randomly assigned to one of two groups , stratified 
by city/SRV site:  intervention and control.  After consent, YMSM are randomized to either the 
control or intervention condition (Intervention, n=240; Control , n=240) . We intend to blind 
participants to the intervention arm assignment in order to improve the internal validity 
of the study, the rigor of the assessment of outcomes, and to minimize bias due to 
awareness of treatment assignment.  
 
For the secondary objective, mystery shoppers will visit  testing sites that have been randomized 
such that each site has an equal likelihood of being shopped on any given day at any given time 
(during normal operating hours).   
 
For the tertiary objective, participants will be randomly selected from participating HIV testing 
sites in each of the three cities. Only sites that have been visited and assessed by study participants will be included in each city’s sample for randomization.  
 
4.0 ELIGIBILITY AND SCREENING  
4.1 Primary Objective  (RCT) :  Inclusion Criteria   
• Assigned male sex at birth and currently identif ies as male  
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 23 of 52 • Aged 15 to 24 years (inclusive)  at time of screening 
• Self-report as HIV -negative or sero -status unaware 
• Speak and read English  
• Not be on PrEP at time of enrollment  
• Report having consensual anal sex with a male partner in the prior 6 months  and/or 
report having not received HIV testing in prior 6 months  
• Reside in Philadelphia, Houston, or Atlanta  
• Access to internet  
 
4.2 Primary Objective  (RCT) :  Exclusion Criteria   
• Assigned female sex at birth  
• Assigned male sex at birth but does not currently identif y as male  
• Aged 14 years or younger or 25 years or older  at time of screening 
• HIV-positive  
• Does not speak or read English  
• Currently taking PrEP  
• Does not reside in Philadelphia, Houston, or Atlanta  
• Currently incarcerated  
• Planning to move out of the region in next 12 months  
 
4.3 Secondary  Objective  (Mystery Shoppers) : Inclusion Criteria  
• Assigned male sex at birth and currently identifies as male  
• Aged 18  to 24 years (inclusive) at time of screening 
• Self-report as HIV -negative 
• Speak and read English  
• Report same sex attraction 
• Reside in Philadelphia, Houston, or Atlanta  
• Able to travel to and from HIV/STI testing sites  
• Access to internet  via a computer or smartphone  
 
4.4 Secondary  Objective  (Mystery Shoppers) : Exclusion Criteria  
• Assigned female sex at birth  
• Assigned male sex at birth but identifies as transgender or gender  non-conforming 
• Aged 17  years or younger or 25 years or older  at time of screening 
• HIV-positive  
• Does not speak or read English  
• Does not report same sex attraction  
• Does not reside in Philadelphia, Houston, or Atlanta  
• Currently incarcerated  
• Planning to move out of the region in next 12 months  
• Unable to travel to and from HIV/STI testing sites  
• Does not have access to internet via a computer or smartphone  
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 24 of 52  
4.5 Tertiary Objective (Site Directors): Inclusion Criteria  
• Speak and read English  
• Site director of an HIV/STI testing site in Philadelphia, Atlanta, or Houston  
4.6 Tertiary Objective (Site Directors): Exclusion Criteria  
• Does not s peak and read English 
• Is not a s ite director of an HIV/STI testing site in Philadelphia, Atlanta, or Houston  
4.7 Recruitment  
For the primary objective, w e will use geographically targeted ads on a range of social media 
outlets . We will work closely with the U19 Management and Technology Cores for guidance on 
recruitment, including use of the Technology Core’s bank of recruitment images. We will also 
recruit from socio -sexual networking sites (e.g., Grindr, BBRT) for YMSM who are 18 year s or 
older. Promotional materials will describe the study and provide a link to the SurveyGizmo 
Participant Eligibility Screener  (see Section 4.0 for eligibility criteria). Once determined eligible, 
YMSM will be contacted to schedule their baseline visit at the SRV.  We will also follow 
respondent -driven sampling (RDS) methods and use a long- chain referral method to supplement 
recruitment, especially with the adolescents (15- 17) who may be harder to reach than young 
adults (18 -24).   
 For the secondary objec tive, we will use geographically targeted ads on a range of social media 
outlets. We will also work closely with the ATN site in each city to recruit in community spaces. If 
an individual is interested in being a mystery shopper, they will complete a Qualt rics screening 
survey to determine their eligibility. If they are eligible, the study team will contact  them for an 
interview . 
 
For the tertiary objective, we will randomly select 10 directors of HIV testing clinics in each city. 
To be included in the sample for randomization, the site must have been visited and assessed by 
participants in the GC study. If a site is selected, the s tudy team will contact the site or the site 
director (if contact information is available)  to schedule an interview.  
 
4.8 Informed Consent  
For the primary and secondary objectives, the informed consent process will occur on the day the 
enrollment visit is  held. Interested persons will arrive to the SRV location, where they will be 
guided through the informed consent process by study staff , who will explain all study procedures 
and answer questions concerning the study and consent process. The research staf f member will 
give the participant as much time as needed and will address any questions or concerns they 
may have. The research staff member will ask the participant questions to gauge comprehension. 
The consent/assent form describes all study procedures,  including confidentiality and privacy, 
information about potential risks, discomforts, benefits of participation, and information regarding 
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 25 of 52 who they can contact with further questions. It also states that participation is voluntary, that 
participants may decide not to take part or to withdraw from the study at any time without penalty 
or loss of any benefit to which they might otherwise be entitled. Participants can refuse to answer any question, and can withdraw from the study at any time. The PIs, Co- PIs, or designee at each 
site will review all informed consents and assents.   
 
Assessing for decisional capacity. For all participants, the study staff reviews the informed 
consent/assent to make an assessment of the youth’s decisional capacity and ability to provide 
consent/assent prior to signing, using a 2- step process. First, the study staff determines if the 
person understands the study goals by asking “Can you tell me what this study is about?” In step 
2, potential participants will be asked questions designed to assess their capacity to understand, 
appreciate, reason with, and express a choice about participation in our specific protocol. 
Participants will be asked to: name things they will be expected to do during the study; explain 
what they would do if they no longer wished to participate in the study ; explain what they would 
do if they experienced distress during the study; and identify potential risks for participating in the 
study. For youth who cannot answer these questions, the study staff will go back and review the 
relevant elements of consent with the participant again and repeat the process. Youth who appear not to understand after repeated review will not be enrolled in the study.  
Waiver of parental consent. We will request that the UNC -CH IRB as the central /single  IRB (IRB 
of Record) grant a waiver of parental consent  to participate in this research study for youth 
participants who are 15 to 17 years of age. The research team has been granted waivers of 
parental permission for prior studies with sexual minority youth. Under 45 CFR 46.408 (c), an IRB 
has the authority to waive parental permission if it determines that “a research protocol is designed 
for conditions or a subject population for which parental or guardian permission is not a 
reasonable requirement to protect the subjects” and “an appropriate mechanism for protecting 
the children who will participate as research subjects is substituted” and “that the waiver is not 
inconsistent with Federal, State, or local law.” A waiver of parental/legal guardian permission will 
be sought given that minor individuals can often seek sexually transmitted infection (STI) and HIV 
testing without parental/legal guardian permission, depending on each site’s state laws. R equiring 
parental permission may place participants at risk for outing themselves as part of the LGBT community or being at risk for HIV infection.  A waiver of parental permission for studies with LGBT 
youth that do not involve greater than minimal risk is a common practice among researchers 
working in the area of gay and lesbian health/mental health. This is done to avoid the selection 
biases operating in only recruiting youth whose parents are both aware of and comfortable with 
their sexual orientation. Commonly, these youth have explored their sexual orientation without 
their parents’ knowledge as the youth struggle with issues of disclosure and its consequences within the social, religious, and economic context of their families. A requirement for parental 
permission in this type of study could not only affect a person’s willingness to participate, but could 
also potentially impact the ability of researchers to engage in this type of research with sexual 
minority youth.  
 
If the purpose of requiring parental permission as stated in CFR is to protect the minor subject, 
then requiring parental permission for youth in these circumstances is not a reasonable 
requirement.  Additional privacy protections are provided in that all assessments, notes, reports, 
and other records will be identified by  only a coded number to maintain participant confidentiality. 
These records and any forms that do contain identifying information (e.g., consent/assent forms, 
contact information) will be kept in a locked, limited access area (such as a locked file cabinet ) at 
the participating site.  
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 26 of 52  
For the tertiary objective, any randomly selected site director who is eligible, willing, and capable 
of being interviewed will be consented over BlueJeans and will be offered a copy of the consent 
form.  
 
4.9 Screening  
Primary objective: Web-based recruitment screener:  
Participants who click on the banner advertisements will be taken to an online screening survey, 
hosted on SurveyGizmo.com, which will include the eligibility script and questions  from the RCT 
Participant Eligibility Screener . For those who meet eligibility criteria, we will ask for a first name, 
email  address, and phone number. For those who do not meet eligibility criteria, there will be an 
option to provide a first name and email address if they want to be contacted about future studies. 
Those individuals who initially screened ineligible because they did not report having anal  sex 
with a man in the past 6 months will be re -contacted to take the online screener again. Web-
based screening instruments allow for real -time data collection across multiple outreach modes 
(e.g., banner ads, flyers, in- person outreach) pooled into a single stream.  We will use Secure 
Socket Layer (SSL) encryption for transfers of information online and data will be stored in the 
secure, HIPAA -compliant servers of SurveyGizmo.  The Emory AC team maintains a business 
partner HIPAA agreement with SurveyGizmo.  
Secondary objective: web- based recruitment screener:  
Participants who have clicked on an online ad or saw an ad in person for the study will be directed 
to an online screening survey hosted by Qualtrics. The survey will include the eligibility script and 
questions found in the Mystery Shopper  Participant Eligibility Screener . Analogous  to 
SurveyGizmo, Qualtrics abides by  HIPAA rules to ensure that data are properly protected and 
best security practices followed. Qualtrics safeguards all customer data, and uses secure data 
centers to ensure the highest protection as per the Health Information Technology for Economic 
and Clinical Health Act  requirements.54 
5.0 STUDY PROCEDURES  
5.1 Enrollment Procedures  
For the primary objective, eligible participants (as identified by screener) will be contacted by 
email and/or phone, and invited to the SRV in their city. Once at the SRV, study staff will consent 
the participants , randomize the participants,  and then provide a computer for the participants to 
complete the baseline survey. Once they have consented, p articipants will be considered formally 
enrolled in t he study. A fter completion of the baseline survey,  study staff will assist participants 
with accessing the WebApp , creating a strong but memorable password, and bookmarking the 
WebApp  (if participants choose to).  If more than 30 days occurs between screeni ng and the 
baseline vis it, eligibility will be re -determined at the baseline visit.   
 
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 27 of 52 For the secondary objective, eligible participants (as identified by screener) will be contacted by 
the study team to schedule an interview. If the individual i s deemed capable and willing, they will 
be consented by a member of the study team.  
 
For the tertiary objective, eligible participants will be contacted by calling the site or the site 
director directly (if contact information is available) to schedule an interview . 
 
 
5.2 Locator/Contact Information  
For the primary objective, at the participant’s baseline study visit, study staff will collect 
participants ’ contact information for follow -up assessments : this information will be entered  into 
SMART  (Study Management and Retention Tool ). We will collect each participant’s  cell phone 
number , email address , as well as encourage them to share their Facebook, WhatsApp, and/or 
Skype usernames , and /or contact information for 2 peers  who could help us contact them in the 
event the participant cannot be reached. Participants will be asked if messages c an be left at 
the peers’ numbers they  provided. Study staff will not leave messages unless expressly 
permitted to do so by the participant. If permission is given to leave messages, site staff will assure participants that messages left with peers  will only ask for the participant to contact study 
staff and will not include any protected health information or information related to study 
participation. Peer contact information will be maintained using the same confidential data 
management practices used for all study data.  
 
For the secondary objective, participants will be asked if they would like to be contacted by 
email, phone, or text message for site visit reminders and other study communication. If 
participant selects the phone option, the study team will ask for explicit permission to leave 
voice messages  that will not include any protected health information or information related to 
study participation . Participant contact information will be maintained using the same 
confidential data management practices used for all study data.  
 
5.3 Randomization Procedures  
For the primary objective, after consent, YMSM are randomized to either the control or 
intervention condition, str atified by city /SRV  site (Intervention, n=240; Control, n=240). 
Participants will be  randomized on a 1:1 basis to either the control or intervention arm.  
 
For the secondary objective, testing sites are randomized by day of the week and time of day. 
After consent and training, participants will work with study staff to find day and time slots for 
their site visits.  
 
For the tertiary objective, 10 eligible testing sites in each city will be randomly selected. The site director for those sites will be contacted for an interview.  
 
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 28 of 52 5.4 Intervention/Investigation Procedures  
5.4.1 Get Connected Intervention 
Participants will complete a 30 - to 45 -minute baseline survey that includes questions on lifetime 
HIV testing history, lifetime STI testing history and knowledge about STIs, date of their most 
recent STI test (if known), and whether they were ever diagnosed with an STI. GC will use 
baseline survey data to select and deliver personalized, tailored content to YMSM assigned to 
the intervention. Furthermore, as part of the participant’s baseline visit, study staff will collect 
contact information where participants may be reached for follow -up assessments. We will use 
best practices to retain participants (e.g., collecting participant’s cell phone number, emai l 
address, Facebook, WhatsApp, and/or Skype username, and contact information for 2 peers 
who could help us contact them). Additional surveys will occur at 1, 3, 6, 9, and 12 months after 
intervention initiation, and can be completed online. These follow -up surveys will repeat many of 
the questions from the baseline survey and will also include additional questions on HIV and STI 
testing in each 3 -month period, including test results. These surveys will be the same for 
participants in the control and interv ention arms.  For participants in the intervention arm, the GC 
WebApp will be retailored after each follow -up survey, based on any different information 
provided on key questions.  
 
5.4.2 Mystery Shoppers  
Two mystery  shoppers will visit each location separately. Each HIV/STI/PrEP clinic will require 
two round- trip visits during the mystery  shopper phase. There are up to 60 registered HIV 
testing sites offering free HIV tests for men within each city’s 25- mile radius: Atlanta ( up to 20 
sites), Houston ( up to 26 sites), and Philadelphia ( up to 55  sites). We will use time space 
sampling to ensure that varying days (weekdays versus weekends when applicable) and times 
(e.g., morning versus afternoon or evening) are selected for visits, thereby maximizing the 
chance of getting different counselors at each agency. The project manager will create a 
calendar for mystery  shoppers to know when and where they will be getting tested.  We will 
reimburse the mystery  shoppers for all charges linked to their testing experiences. Mystery 
shoppers will be instructed to be honest about their sexual behaviors during their visits. By avoiding creating ‘personas’ or ‘scripts ,’ shoppers will incr ease the social validity of the 
assessment and avoid arousing suspicion due to exaggerated or unrealistic scenarios. Upon completion of a testing visit, the mystery  shoppers will complete the Qualtrics site follow -up 
survey  immediately. Mystery shoppers wi ll also be asked to summarize their qualitative 
impressions using an open text field. 
 
5.4.3 Assessment of sites’ satisfaction with biannual  performance reports  
Directors of ten randomly -selected agencies in each city will participate in a one -time 60 -90 
minute semi -structured interview that will focus on 4 domains: (1) existing prevention services 
used and/or promoted by the agency, (2) agency (internal) resources currently missing, that if 
identified and addressed, could improve delivery of HIV/STI and PrEP services to YMSM, (3) 
feedback on the biannual evaluation assessments and their use for service- delivery  
improvements, and (4) the advantages and disadvantag es of GC rollout within ASOs. We will 
interview providers via video conference in a private office at the University of Pennsylvania to 
maximize candidness and privacy while decreasing travel -related costs. We will use BlueJeans, 
a simple and low cost alternative that requires no server infrastructure to set up or maintain and 
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 29 of 52 allows providers to be HIPAA -compliant. The iTech Technology Core will facilitate access to and 
provide any technical support needed.  
5.4.4 Mystery Shopper  Training:  
We will work wit h the ATN site in each city  to recruit and enroll HIV -negative YMSM (ages 18 -
24) who are interested in serving as mystery shoppers. We plan to recruit and enroll a diverse 
group of 10 -15 mystery shoppers per city.  
Shoppers will be trained to work with our site  assessment tool  to optimize standardized data 
collection across sites. A key aspect of the training will be role- playing  through mock clinical 
scenarios . They will also receive training to strengthen their self -efficacy to feel empowered as a 
client. Specifically, we will conduct role- plays with different scenarios and interactions that might 
occur during a visit. We will underscore the importance of being well versed in their rights and 
procedures, and provide skills on how to respond to worst -case scenarios (e.g., how to turn 
down any unwanted procedures) were they ever to occur.  
 
5.4.5  Intervention Monitoring/Quality Control  
The RCT will be managed through weekly site meetings, monthly meetings with iTech Core Leaders, and annual meetings. Research staff will meet regularly to ensure standardization of 
procedures, and share details on recruitment strategies. Standardization of  RCT activities will 
be ensured by providing consistent training to all study staff and by using a central research 
protocol that will be developed for the project to ensure guidelines are followed.  
 
6.0 EVALUATIONS AND MEASU RES  
6.1 Behavioral Evaluations  
6.1.1  Pre-intervention ( Baseline) Evaluations/ Measures  
• Socio -demographic information:  We will include questions on race/ethnicity, educational 
attainment, employment status, housing status, and history of incarceration, sexual 
identity, and “outness” to their social network.  
 
• HIV Testing:  The baseline survey will include questions on HIV testing history.  
 
• STI Testing:  At baseline, we will assess STI testing history and knowledge about STIs. 
We will ask participants what STIs they have been tested for, the date of their most 
recent STI test (if known), and whether a medical provider has ever diagnosed them with an STI.   
 
• Mechanisms of Change:  We will assess YMSM’s psychosocial correlates predicted to 
adopt HIV services (i.e., Attitudes, Norms, Self -Efficacy , and Behavioral Intentions to get 
HIV tested). Integrated Behavioral Model constructs will be assessed with 3 subscales 
assessing YMSM’s attitudes, social norms, and behavioral intentions
59 that we have 
used in the past with this population60. Each attitude item is measured with three five-
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 30 of 52 point semantic differential scales (good -bad; worthless -valuable; pleasant -unpleasant). 
Social norms assess the extent to which par ticipants felt that friends and family believed 
he should test for HIV on a 1 to 5 scale. Behavioral intentions items assess participants’ 
intention to adopt HIV testing, on a 1 (very unlikely) to 5 (very likely) scale. Self -efficacy 
to access HIV/STI serv ices and to discuss sexuality -related issues with provider will be 
ascertained, as well as YMSM’s perceived confidence of visiting a testing site or requesting a home kit.  
 
• Sexual Risk Behavior :  Sexual risk behavior will be assessed using the Sexual Pract ices 
Assessment Schedule used in previous online studies with YMSM
61,62 to explore the 
number of occasions of different sexual acts (oral, anal; receptive, insertive) with three 
different types of partners (romanti c interest, casual partner “hookup,” or friend with 
benefits), use of condoms during the past 3 months, and knowledge about partners’ HIV 
status and PrEP use. Assessments ascertain sexual behaviors with male and female 
partners, and will be asked at each f ollow -up. At -risk sex will be defined as any anal 
intercourse without condoms and/or PrEP that occurs with a person of known positive or 
unknown sero -status. We will assess the number of partners with whom participants had 
“at-risk sex. ” 
 
• PrEP Awareness an d Willingness:  The survey will contain a brief  description of PrEP to 
orient the participant. Questions are adapted from recent studies of PrEP attitudes with 
YMSM5,6,40. PrEP awareness will be a single item measure of whether the participant 
has heard of PrEP57 (yes/no/I don’t know ). PrEP willingness will be measured with an 
existing 8 -item scale developed for YMSM58 to gauge likelihood of PrEP use across 
different conditions (e.g., partner types; experiencing potential side effects).  
 
• Technology and Social Media Use:  Given the online interface of the intervention, we will 
include P ew Internet Survey questions27 regarding use of different devices, the number 
of hours spent online through each device, the re asons for social media use, sites 
commonly frequented, and extent to which the Internet supplements face -to-face 
interactions. We will also measure AMSM’s frequency of use of social media to look for 
HIV or sexual health- related information60,71, and their online partner -seeking 
behaviors72,73 
 
• ATOD (alcohol, tobacco,  and other drug) use:  We will assess frequency of ATOD use 
(as measured in NSDUH) over the past 30 days (3 months in 3- , 6-, 9-, and 12- month 
follow -up surveys) for alcohol, tobacco products , cannabis , cocaine, amphetamine type 
stimulants , inhalants, sedatives or sleeping pills , hallucinogens,  and opioids63. We will 
also ask age of onset. If respondents indicate alcohol use, we will ask the Alcohol Use 
Disorders Identification Test (AUDIT) developed by the WHO  (World Health 
Organization) . AUDIT64 is a 10 -item screening questionnaire with 3 questions on the 
amount and frequency of drinking, 3 questi ons on alcohol dependence, and 4 on 
problems caused by alcohol.  
 
• Psychological Distress:  We will measure this using existing, well -validated scales. We 
will use subscales from the Brief Symptom Inventory65 to measure depressive symptoms 
and anxiety symptoms. Depressive symptoms include 6 items rated on a 5- point scale 
(1=never, 5=very often). Items include feelings of loneliness, blue or sad, and having 
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 31 of 52 thoughts of ending one’s life. Anxiety also includes 6 items measured on the same 5-
point scale and includes  reporting nervousness or shakiness, feeling fearful, or suddenly 
scared for no reason. We will use the 10- item Rosenberg Self -Esteem66, measured on 4 -
points (0=Strongly disagree- 3=Strongly agree).  
 
6.1.2 On-study Evaluations/ Measures  
• HIV Testing:  Follow -up surveys will repeat the HIV testing  questions in each follow -up 
survey . The HIV testing outcome will be:  the proportion of MSM tested for HIV two  or 
more times at least 3 months apart in the 12 -month follow -up period (“frequent tester”). 
As an additional analysis, we will also examine the proportions of participants who receive one HIV test.   
 
o Among self-reported newly diagnosed HIV+ cases, we will measure their linkage 
and engagement with appropriate medical care after initial diagnosis using criteria 
employed in prior ATN protocols with youth24,67- 69. We will define linkage as an 
HIV-related medical visit within 45 days of referral, and engagement as a second 
HIV-related medical visit within 16 weeks of initial visit68. Onset of ART initi ation, 
self-reported adherence to ART, and viral suppression are exploratory 
indicators67, as we recognize that our follow -up period may not be a sufficient 
amount of time to see these changes.  
 
• STI Testing:  The STI testing outcome is defined as the proportion of YMSM tested for 
STIs at least once in the 12- month follow -up period. We will ask participants what STIs 
they have been tested for, the anatomic sites where they were tested, the date of their 
most recent STI test (if known), and whether a  medical provider had diagnosed them 
with an STI. In the follow -up surveys, we will ask participants whether they had been 
tested for STIs in the past 3 months  (for the 1 -month follow -up survey, we ask about the 
past 30 days).  If STI testing is reported,  we will ask participants  to indicate what tests 
they received,  and whether they were  diagnosed with an STI by a  medical provider.  
 
• PrEP Use:  At each follow -up assessment, PrEP -eligible HIV -negative YMSM (per CDC 
guidelines) will be asked whether they have begun using PrEP6. We will also ascertain if 
a provider r ecommended PrEP and/or were offered a prescription for PrEP . 
 
Site Evaluations:  Across both trial arms, YMSM who report testing in the prior 3 months 
will complete self -evaluation forms of their testing experiences to assess comfort, 
quality, and concerns after visiting a site for HIV/STI testing and PrEP prevention 
services. The asse ssment form is the same form used by the mystery shoppers. We will 
use these data to update the WebApp and to send aggregate data of YMSM’s 
satisfaction with services to agencies biannually.  
 
• Intervention Acceptability:  At each follow -up, YMSM will report  data on the acceptability 
of their assigned arm.  We will also use the Systems Usability Scale70 to ascertain 
participants’ overall satisfaction with the intervention, perception of the information 
quality, and perceived usefulness of their intervention to improve their health.  
 
• Use of I ntervention over time:  We will measure intervention exposure using paradata 
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 32 of 52 (e.g., process data emerging from use of the WebApp) from backend database of the 
intervention website, including counts of user sessions, session lengths, pages visited,  
and functions utilized. This information will assist in examining whether intervention 
dosage influences the overall efficacy of the intervention, and inform the cost analysis 
and wider implementation and scalability.    
 
6.1.3 Premature Discontinuation/Off -Study Evaluations/ Measures  
RCT p articipants  who request voluntary withdrawal and discontinue study participation after the 
Baseline survey but prior to the completion of the final survey at 12 months  will be contacted by 
SRV staff in an attempt to understand the reason (s) for the  participant’s  withdrawal and to 
potentially improve the service experience of the study and refine procedures .  
 
Participants  who are prematurely discontinued by a study PI  or SRV staff will not be allowed to 
re-enroll into the study.  Reason(s)  for study discontinuation will be recorded through a CRF.  
 
7.0 DATA COLLECTION AND SITE  MONITORING 
7.1 Development of Protocol and Case Report Forms  
The Protocol Team  in collaboration with the Management  Core  and Analytic Core , is 
responsible for the development of this protocol as well as the Case Report Forms (CRFs) 
needed to collect the information required to implement this protocol.  
 
7.2 Data Records  
Participant -related study information will be identified through a study  ID number ( SID) on all 
participant CRFs, audio  files, transcripts, and Computer Assisted Self Interviewing (CAS I) files. 
Participant names or other personally -identifying information will not be used on any study 
documents  and will be redacted from inter view transcripts . Participant names and their S ID will 
be stored separately  from other study information in SMART, accessible only to designated 
study staff, iTech site monitors, and representatives from the NICHD.  SIDs will not be entered 
into the WebApp; instead,  a unique WebA pp ID will be assigned to each participant when they 
creat e an account for  the WebA pp. These unique Web App IDs will be provided by the 
developer.  Original source documents for individual participants will be maintained at the 
respect ive SRV and will be accessible only to the study staff. Data from original source 
documents will be transcribed on CRFs as applicable.  
 
7.3  Data Collection  
7.3.1  CRFs  
Study monitoring data, including untoward effects will be collected on CRFs . All CRFs for this 
study will be completed  through iDataFax, an electronic CRF system.   
 
7.3.2.  Mystery Shopper Data  
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 33 of 52 For the second objective, mystery shopper participants will video chat, audio chat, or chat in-
person with a study team member about  every site visit , following the visit(s) . If a video chat 
occurs, the BlueJeans platform will be used.  These conversations are designed to give mystery 
shoppers an opportunity to discuss and process their visit and any notable incidents at a point 
when the visit is very recent and easily memorable. If any troublesome or adverse events are 
reported to the study team member, the study team member can provide the participant with 
support and external services, in addition to documenting the incident.     
 After each visit, Mystery Shoppers will complete a brief evaluation of the site using a web- based 
CASI at the SRV.  All survey data will be collected using Qualtrics. Data  will remain confidential;  
no personal identifying information will be collected during the computer session. The 
participant’s unique SID# will be used in order to link the interview responses to the participant’s  
CRF data. We will download the data directly from the administrative web application interface 
and manage it using Microsoft Excel.  The data collected will be stored in a database held within 
a University of Pennsylvania secure server.  
7.3.3 CASI Data  
Data collected using a web -based CASI method will be on a portable computer , tablet,  or mobile 
phone via an internet -based application. All survey data will be collected using SurveyGizmo. 
Data  will remain confidential;  no personal identifying information will be collected during the 
computer session. The participant’s unique SID# will be used in order to link the interview 
responses to the participant’s CRF data.  
Self-administered surveys will be done at baseline and months 1,  3, 6, 9, and 12. They  will be 
completed by participants on personal devices  or laptop or desktop computers  via surveys 
hosted on SurveyGizmo.com . We use SSL encryption for transfers of information online and 
data will be stored in the secure, HI PAA- compliant servers of SurveyGizmo. The Emory AC 
team maintains a business partner HIP AA agreement with SurveyGizmo.  
7.3.4  CASI Data Security  
To ensure data privacy, as soon as data is entered (in real -time), it will be encrypted during 
transmission to the AC using Secure Socket Layer (SSL) technology. The data will then be 
immediately stored in a secure database on an AC server within the AC data center.  
 
The survey data collected through SurveyGizmo utilizes Amazon Web Services servers for 
hosting, located in controlled data center facilities in Boulder, Colorado.  We clean, manage, and 
download the survey data directly from the SurveyGizmo application interface. The survey data 
collected through SurveyGizmo is encrypted while in transfer using SSL certificates, encrypted 
at the disk level in the Amazon Web Services database servers, and encrypted at the row level. 
Access to the SurveyGizmo account where the data can be downloaded is password- protected 
with a sufficiently complex password. The data collected through our web application is encrypted while in transfer using SSL certificates and access to the administrative web 
application where the data can be downloaded is password- protected using sufficiently complex 
passwords for each approved user.  
 
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 34 of 52 7.3.5  BlueJeans Platform Description  
For the mystery shopper debriefing sessions that occur over video chat, the BlueJeans platform 
will be used . BlueJeans is compatible with PCs, Macs, and any device with a web browser, 
including tablets and smartphones. Unlike other video- chat platforms (e.g. Skype), BlueJeans is 
HIPAA- compliant. BlueJeans includes the following functions to protect users:  
 
Medi a handling and encryption.  In WebEx, Vidyo, Tandberg, and Polycom architectures, media 
is sent to a server (also called a video relay or MCU). Although encryption is applied from the 
user’s computer to these servers, the servers still have full access to the user’s media. In 
contrast, Blue Jeans does not record or store your information; they simply encrypt and transmit 
it. Blue Jeans Network does not store any video conference content, in any format. This security 
infrastructure means Blue Jeans has no control over the content shar ed via video conference. 
BlueJeans supports standards -based encryption (AES -128) for video conferencing. .  
 
Infrastructure and network security. BlueJeans employs a wide range of security management. 
This includes network firewalls throughout the infrastructure to create security zones for different 
applications and services. BlueJeans also deploys proxy servers that terminate all third 
party/customer traffic at a proxy layer. All web traffic passes through industry -leading load 
balancers to protect against  a suite of application attack vectors. Beyond the firewall, proxy 
servers, and load balancers, BlueJeans also periodically scans for network, port, and 
application- level vulnerabilities. Vulnerability scans are conducted by a leading third party SaaS 
provider, in addition to some special -purpose, in- house scanning tools. Furthermore, all of the 
third party applications and operating system software is checked for security advisories and is 
patched periodically. Routers, firewalls, load balancers, and proxy  application servers are all 
configured to mitigate numerous types of DOS attacks. BlueJeans also engages with third party 
consultants to perform penetration testing of the service.  
 
No-install client.  Video conferencing software clients tend to be large and to leave a big footprint 
on the user’s system. Almost all of them require administrator permissions to install.  
Once the client software gains administrator permissions, they can severely compromise 
computer security. BlueJeans offers browser -based conf erencing system that does not require 
administrator permissions or installation.  
 
BlueJeans offers the HIPAA -required Business Associate Agreement (BAA) where BlueJeans 
agrees to be responsible for keeping all patient information secure and to immediately report 
any breach of personal health information. In this study, University of Pen nsylvania will maintain 
a BAA with BlueJeans, and this will be extended to cover the proposed activities. The 
BlueJeans sessions will include identifying information (e.g., images of the participant, voice 
recordings). All identifying information will be s tripped from the recorded BlueJeans sessions 
before they are sent t o the analysis team for content analysis.   
 
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 35 of 52 7.4 Data Submission  
7.4.1  CRFs  
Although the iTech projects will involve substantial online follow -up, we will use CRFs to collect 
data on study m ilestones such as completion or discontinuation, protocol deviations, any social 
impact reported by participants, and adverse events (AE s).During study conduct, the SRVs will 
complete  electronic CRFs , transmit  to the AC using i DataFax, a leading multi -site database 
environment for HIV RCT. DataFax can receive and transcribe CRF data via fax and scan, or 
allow for direct data entry. It provides for monitoring form completion and data- quality, and a 
system for data querying and resolution with SRVs, while mai ntaining an audit trail. The AC 
uses DataFax for MSM studies and RCT s and maintains a secure  DataFax Linux  server at 
Emory.  
7.4.2  Audiotape Data  
 
Interviews w ith agency directors w ill be audio- recorded to allow for verbatim transcription of the 
interview, and checked for accuracy and completion. We will format all transcripts and i mport 
them into qualitative data analysis software. Data analysis will be primarily conducted by Drs. 
Stephenson and Bauermeister, and will also involve ATN members from the Analytic Core  and 
Get Connect study team members  when appropriate. After one year when the study is over, 
audio recording s will be destroyed.  
 
7.4.3  CASI Data Transmission 
 
Only authori zed users will be able to access and open the survey through SurveyGizmo . To 
ensure data privacy, as soon as data is entered (in real -time), it will be encrypt ed during 
transmission to the A C using Secure Socket Layer (SSL) technology . The data will routinely be 
downloaded and stored in a secure database on an  AC server within the A C data center.  
 7.4.4 Retention data  
 
The study will use a HIPAA -compliant web- based platform entitled Study Management and 
Retention Toolkit (SMART), which is a SaaS (Sof tware as a Service) based mobile application 
aiding studies with various aspects of participant recruitment, study implementation, and retention. The application has the ability to securely manage participant information across 
multiple studies and custome rs simultaneously, stratifying participant information by study and 
site. SMART includes an admin web portal and a participant facing mobile app (optional), which allows for secure messaging, study calendar management, self -scheduling by participants, 
secu re photo uploads, and longitudinal tracking of participants from screening to study 
completion. The ability to designate specific roles to all SMART users allows for greater control 
around permissions and accessibility to participant information. Users can even be limited to a 
reporting only role, which allows for study oversight through real time aggregate reporting, but no 
access to PHI. SMART is a licensed service of the Center for AIDS Research (CFAR) at Emory 
University, Prevention Science Core. Utiliz ation of the mobile app is optional and the admin web 
portal will fully function without it.  
 
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 36 of 52 As a backup in the event that the web portal is down or SRVs cannot access it, t he study will use 
a non- web-based version of SMART, which maintains all contacts and scheduling records into a 
dynamic database that can be queried, in order to facilitate participant retention and 
communication. SMART was developed by the Emory Tech Core team in a Microsoft Access and 
SQL (Structure d Query Language) Server environment. All data will be stored on an  SQL server 
in the "trusted zone" ( HIPAA compliant) area of the Emory Rollins School of Public Health 
computing service. Access to this database requires user permissions, connection to the Emory 
network via a VPN, and two- factor authentication using Duo. Daily backups of the entire database 
are performed. In the event that there are technical difficulties with site access to the Emory SQL Server environment, the SMART back -end database file will be stored in a user -restricted folder 
on the Emory network (the “T: drive research share”, which requires secure Emory VPN access 
and two- factor authentication. If there are difficulties with the VPN connection to the Emory 
network, then a password- protected Microsoft Excel version of SMART will be made available to 
SRV users in their site -specific (and user -restricted) Box folder. These back -up systems provide 
a comparable level of data security and will be limited to the same number of users as the primary 
management system. These back -up systems are necessary for ensuring secure maintenance of 
study data, and secure, uninterrupted access to study data.  
 
7.5 Data Quality Assurance  
Investigators receiving federal funding must adhere to the Code of Federal Regulations (CFR) 
to protect research participants and produce reliable study information. The iTech AC will 
monitor  data entry and will have an internal quality assurance plan that  will identify problems 
and correct errors in research study records . 
 
7.6 Role of Data Management  
The AC will provide instructions concerning the recording of study data on the CRFs, and entry 
of the data into the AC data management systems.  
7.7 Study Sit e Monitoring and Record Availability  
Site monitors from the M C and AC  will visit participating study sites to review a selected portion 
of the individual participant records, including assent/consent forms, CRFs , and supporting 
source documentation to ensure the protection of study participants , compliance with the 
protocol, and accuracy and completeness of records . Regulatory files, as required, will also be 
inspected to ensure that regulatory requirements are being followed.  
 
The site investigator will ma ke study documents (e.g., assent/ consent forms, case report forms) 
and pertinent hospital or clinic records  readily available for inspection by the local IRB, the 
central IRB, the site monitors, the NICHD, the Office for Human Research Protections (OHRP), 
or the sponsor’s designee for confirmation of the study data.  
 
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 37 of 52 8.0  PARTICIPANT MANAGEME NT 
8.1 Tracking RCT Participants for Follow -up 
For the primary objective, participants  will be emailed  once the appropriate time period has 
elapsed (30 days af ter baseline, 2 months after the 1- month survey, and 3 months after that for 
all other follow -up surveys), to notify them that a new follow -up survey is available.  Multiple 
contact methods will be used for participants  who do not complete their follow -up surveys after 
being emailed (e.g., phone calls , alternative email  addresses , text messages, Facebook /other 
social media accounts ). Participants  will be asked whether or not messages can be left for any  
phone numbers they provide. They will be informed that  messages will not contain any 
information regarding the nature of the project.  
  
8.2 Compensation  
For the primary objective, participants will be able to earn up to $155 total : Baseline survey = 
$20, FU1 (Month 1) = $20, FU2 (Month 3) = $25, FU3 (Month 6)  = $30, FU4 (Month 9) =$30, 
FU5 (Month 12) =  $30. This is the standard compensation used by both Drs. Bauermeister and 
Stephenson in their ongoing YMSM studies, each of which has maintained >90% retention. We 
back -loaded the FU incentives to encourage completion of all data collection time points and 
reduce participant attrition over time.  To receive the month one survey incentive, participants  
must complete the survey within 30 days of receiving the email with their  unique survey link. To 
receive their month three, six, nine, and twelve survey incentives, participants  must complete 
the surveys within 45 days of receiving each email with their  unique survey link.  
 
For the secondary objective, participants will earn $100 for the training session and $50 per site 
visit. The site visit includes an appointment at the designated site, completion of the post -visit 
survey, and a debriefing session with a member of the study team.  
 
For the tertiary objective, site directors  will not be compensated for the qualitativ e interview.  
8.3 Intervening on “Social Harms"  
All sites have specific policies governing the treatment of human participants . These policies 
specify that medical and psychological assistance will be available in the immediate 
environment in the event a participant should experience any adverse reactions resulting from 
study procedures.  
While participants will be informed that they may refuse to answer any question at any time, 
responses or reactions to certain questions may indicate distress on the part of the participants . 
If at any time during the study, a participant divulges that he is at risk for harm, including but not 
limited to being abused or experiencing violence, if harm is suspected or likely, or if the 
participant states he is suicidal/homicidal, measures will be taken to ensure his or her safety . 
Reporting will be done as appropriate to the situation and the legal st atutes, including reporting 
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 38 of 52 to child protection agencies or other appropriate agencies and referrals will be provided to 
appropriate support, counseling , or treatment resources . 
 
8.4 Criteria for Premature Study Discontinuation  
The principal investigator has the authority to withdraw any participant at any time if it their opinion 
it would be in the best interest of the participant. The participant will be informed of this withdrawal 
and explained the rationale. Withdrawal will be documented in the study tr acking system.  
 
For the primary objective, participants  will be prematurely discontinued from the study if any of 
the following occurs:  8.4.1  The participant withdraws consent /assent  (see below) ;  
8.4.2 The study is cancelled by the NIH (or iTech, or other administrative entity);  
8.4.3 The study is cancelled for other administrative reasons;    
8.4.4  The participant becomes incarcerated or placed in detention during the study  
8.4.5  The participant reports an HIV positive diagnosis ; or  
8.4.6    Death of the participant . 
 For the secondary  objective, participants will be prematurely discontinued from the study if any 
of the following occurs:  
8.4.7 The participant withdraws consent (see below);  
8.4.8  The participant is found to be dishonest about  their site visits;  
8.4.9 The study is cancelled by the NIH (or iTech, or other administrative entity);  
8.4.10 The study is cancelled for other administrative reasons;    
8.4.11 The participant becomes incarcerated or placed in detention during the study; or  
8.4.12  Death of the participant.  
 For the tertiary objective, participants will be prematurely discontinued from the study if any of 
the following occurs:  
 
8.4.13  The participant withdraws consent/assent (see below);  
8.4.14 The study is cancelled by the NIH (or iTech, or other administrative entity);  
8.4.15 The study is cancelled for other administrative reasons;    
8.4.16 The participant becomes incarcerated or placed in detention during the study; or  
8.4.17  Death of the participant.  
 
Participants may end their participation in the study at any time.  No further data collection will 
occur from the date the decision is made to permanently discontinue the subject from the study. Participants who experience distress during the survey can access our list  of community 
referrals, which can be viewed on our study's website, or contact the research staff using the 
information provided to the participant within the consent /assent  process. Any unexpected 
adverse events that meet the New Safety Information repor ting criteria will be immediately 
reported to the UNC -CH IRB and the respective sites’ IRBs if applicable. A ll study activities will 
halt pending UNC- CH IRB review and recommendations  if necessary . If a participant withdraws 
from the research, all data col lected in the interview will be immediately destroyed and will not 
be used in subsequent analysis.  
 
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 39 of 52 For all objectives, i f a participant withdraws or is removed from the study, t he Get Connected Off 
Study Form will be c ompleted.  
 
9.0 MONITORING UNTOWARD EFFECTS ASSOCIATED W ITH OR RESULTING FRO M 
STUDY  
Site staff must first follow their own IRB’s procedure for reporting and managing untoward 
effects.  
 
There are three types of untoward effects to be identified: (1) those related to the participant, (2) 
those related to the site visits by mystery shoppers , and (3) those related to the 
neighborhood/community  (if applicable).  
 
First, the study will catalogue any untoward effect related to the participant . Reporting is 
required for occurrences including social harms, psychological distress , and serious life 
threatening events such as suicide attempts . These may be immediately apparent to the study 
staff, such as the participant’s emotional upset state requiring referral for counseling; or they 
may be delayed and reported later to study staff, such as physical harm to an individual for having participated in the study. Study staff will notify the team of these untoward effects using 
the iTech QNS accessi ble through the iTech  website ( https://itechnetwork.org
). Study staff will 
be briefed during the training on the scope of possible untoward effects and instructed to report 
events.  
 Second, mystery shoppers  may encounter untoward events during sessions that personally 
affect them. Training and guidance will seek to minimize this risk. Nonetheless, an assessment of the cost of conducting this study must include cataloguing these events as well. The protocol 
chairs should be notified of these events so that they may be immediately addressed, 
evaluated, and guidance modified or expanded to minimize similar risk to other study staff.  
 Third, this community -based study intends to evaluate i ts impact in site -level service delivery , 
including unexpected effects of the project on the community . This will be done both formally 
(through in- depth interviews) and informally through community dialogues with ATN sites,  with 
untoward events being reported to the protocol team.  
 
10.0 STATISTICAL/ANALYTIC  CONSIDERATIONS  
10.1 Introduction  
10.1.1  We will test the efficacy of GC in increasing HIV -negative or HIV -unknown YMSM’s 
successful uptake of HIV and STI testing (e.g., routine HIV/STI testing) and increase in PrEP 
awareness and w illingness, as compared to the attention- control condition over a 12 -month 
period. Descriptive statistics of the psychosocial and demographic characteristics of the 
participants will be described for all and by intervention group. These will be compared be tween 
treatment groups using t -tests or Wilcoxon rank sum tests for continuous variables and chi -
square tests for categorical variables. To test for intervention efficacy, we will conduct primary 
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 40 of 52 analyses of our primary outcomes using regression analyses t o compare our treatment group to 
the control using the appropriate link function (identity for continuous outcome, logit for binary 
outcome , and natural log for count outcomes). The regression will be run with group assignment 
only in the model, as well as , controlling for participants’ socio- demographic characteristics, 
ATOD and psychological distress, and intervention- related process data (e.g., frequency of use, 
acceptability). Interactions between group assignment and these characteristics will be tested to 
explore potential moderators of treatment effect. We will repeat these analyses for the 
secondary outcomes (e.g., theoretical mediators )). 
10.2 Power Estimates  
10.2.1  The primary outcomes for the proposed trial are HIV -negative and HIV -unknown 
YMSM’s  successful uptake of HIV and STI testing willingness  (e.g., HIV/STI testing), and PrEP 
awareness and willingness. For HIV testing, we define power as correctly identifying the 
difference in the proportion of YMSM who engage in HIV testing 2 or more times at least 3 
months apart in the 12- month follow -up period (“frequent tester”) in our treatment arm (GC) vs. 
our attention- control arm. For STI testing, we define it as receiving at least one STI test  during 
the 12 -month follow -up period. For proportions (e. g., HIV testing; PrEP awareness), our sample 
size calculations are based on a two- sample test of proportions using a two- sided significance 
level of 0.05. In order to have 80% power to compare GC to the attention- control group, we 
require at least 400 part icipants to find an absolute difference of 13% in cross -sectional 
analyses . Assuming within -person correlation of 0.25, we can detect an 8.8% difference. A less 
favorable within- person correlation of 0.75 allows us to detect an 11.3% difference .  
10.3 Statistical Analysis Plan  
10.3.1 We will use the general framework of generalized linear mixed models (GLMM) to test for 
intervention effects over time. Note that some of our outcomes are binary, some count and 
some continuous traits , and thus need to be treat ed differently. The general form of the GLMM 
will be g( 𝜇𝜇𝜇𝜇𝜇𝜇)=𝛽𝛽0𝜇𝜇+𝛽𝛽cov 𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝜇𝜇𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝜇𝜇𝜇𝜇+ 𝛽𝛽Time𝜇𝜇+ 𝛽𝛽𝛽𝛽𝐶𝐶𝐶𝐶Arm𝜇𝜇+ 𝛽𝛽Arm x Time, where  𝛽𝛽 is the mean 
response corresponding to subject i at Time j (baseline and 4 follow -ups), with its appropriate 
link function (identity for continuous outcome, logit for binary outcome and natural log for count 
outcomes); 𝛽𝛽𝐶𝐶𝐶𝐶 =1 if the i -th subject is in the intervention group and 0 if the i -th subject is in the 
attention- control group. The interaction coefficients are of interest here, measuring the 
difference in the rate of change in outcome across the two treatment groups over time. The 
subject -specific r andom intercepts are assumed to be normally distributed with a common 
variance and they account for within- person correlation. We will also explore if we need a 
subject -specific random -slope corresponding to visit in the above model. Maximum likelihood 
estimation will be used for fixed effect parameters. Models will be compared according to 
information criterion like AIC, BIC. For some binary outcomes like HIV testing, we will perform an aggregate analysis after collapsing across the repeated measures using simple logistic 
regression comparing whether the probability of having tested at least once over the entire FU 
period is different across treatment groups, after adjusting for baseline values. To ensure 
robustness, we will also apply an exchangeable worki ng correlation structure to its 
corresponding generalized estimating equation (GEE) model. We will also conduct exploratory regression analyses to examine city differences  in the outcomes . These regressions will be run 
with group assignment and city  in the  model, controlling for socio- demographic characteristics. 
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 41 of 52 Interactions between group assignment and city  will be tested to explore potential site -specific 
moderators of treatment effect.  
10.3.2 As a secondary analysis, we will build on our GLMM framework to examine whether the 
intervention effects in the theoretical mediators (e.g., intentions, self -efficacy, perceived barriers ) 
are associated with our outcomes. We will also test whether these relationships vary as a 
function of YMSM’s varying engagement with the intervention (intervention acceptability; use of 
intervention over time). Interactions between group assignment and these characteristics will 
test for potential moderators of treatment effect.  
10.3.3  For the qualitative interviews of agency direc tors, i nitial reading and coding of the 
transcripts will be reviewed, compared, and refined in team meetings. This systematic process 
will lead to the creation of a coding structure that includes a hierarchical set of constructs seen 
in the data. We will analyze several transcripts jointly to establish inter -coder reliability. The 
team will then code all transcripts using our coding structure and add inductive codes throughout the iterative analysis process. Throughout, we will discuss emerging themes, resolve 
difficulties or concerns that may arise while coding, and adapt the codebook as necessary. 
Since we were seeking to gain a multi -level understanding of the structural, organizational , and 
interpersonal barriers and facilitators of implementing GC, our analysis will utilize a 
phenomenological framework
74. Although our analysis will rely primarily on a phenomenological 
inductive approach, we will also employ aspects of deductive analysis that take into account our 
guiding conceptual framework. This combination of analytic strategies wil l allow us to conduct a 
phenomenological analysis (inductive) that was initially informed by existing research and theory via the conceptual framework (deductive). We will analyze the qualitative data using thematic 
analysis until we have reached saturation
55,56,75. 
10.4 Missing Data  
Several procedures will be used to conduct data anal ysis when data for either outcomes or 
covariates are missing. The first step will be to assess the extent and pattern of missing data. If 
data are missing for only a few cases, then data analysis will be conducted only on study 
participants with complete data. However, when such a strategy would result in loss of data 
from a substantial proportion of participants, or if this approach would lead to biased or 
inaccurate results, then some form of imputation will be performed. The form of imputation used 
will depend on the nature of the data that are missing. For example, data that are collected 
repeatedly might be imputed using the “last value carried forward” method; and in some instances, interpolation between neighboring points might also be used.  
 
When th e primary endpoint is missing, one data analysis will be conducted using only cases 
with the endpoint. Subsequent analysis will be done where missing endpoints are imputed. Hot -
deck imputation or regression imputation may also be used in this context.  
 
11.0 HUMAN SUBJECTS  
This study will be conducted in compliance with the protocol, ICH Good Clinical Practice 
guidelines, and 45 CFR Part 46.  
 
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 42 of 52 11.1 Participants’ Confidentiality  
All questionnaires, evaluation forms, reports, transcripts, and other records will  be identified by a 
coded number only, to maintain participant confidentiality . All records with personally -identifying 
information will be kept in a locked  file cabinet in a limited secure access area at each SRV site. 
All computer entry and networking programs will be done with coded numbers only . Clinical 
information will not be released without written permission of the participant, except as 
necessary for monitoring by the MC or NICHD.  
 
Every effort will be made to ensure that study participants are protected from risks. The main 
risk specific to the role of the Analytic Core is breach of confidentiality.  
Breach of Confidentiality:  A potential risk to participants is violation of confidentiality. We will 
take the utmost caution to protect the confidentiality of all responses. We will minimize this risk 
by maintaining confidentiality and discretion throughout all iTech research procedures and data 
management and analysis.  
Participants may be concerned about the security of their data, particularly si nce it is collected 
and stored electronically. The Analytic Core has significant experience developing security 
protocols for Internet -based studies, and we will take a variety of steps to ensure participant 
security, including using a dedicated server behind a firewall, encryption of data, separation of 
identifiers from responses, and password- protected access to data. Therefore, we believe that 
this risk will be minimal. All of the apps and websites included in the iTech have features to 
ensure app securi ty and privacy.  
11.2 Certificate of Confidentiality  
This research specifically targets a vulnerable population, children - YMSM ages 15- 17. We will 
take every available step to minimize the risk of identifying/linking data being subpoenaed, 
stolen, or inadvertently released. First, p er Section 2012 of the 21st Century Cures Act  as 
implemented in the 2017 NIH Certificates of Confidentiality Policy , all ongoing or new research 
funded by NIH as of December 13, 2016 that is collecting or using identifiable, sensitive informa tion is automatically issued a CoC.   As noted on the NIH website 
(http://grants.nih.gov/grants/policy/COC/faqs.htm#187), a Certificate of Confidentiality will help the research team “...avoid compelled ‘involuntary disclosure’ (e.g., subpoenas) of names and 
other identifying information about any individual who participates as a research participant  (i.e., 
about whom the investigator maintains identifying information) during any time the Certificate is in effect.” We have applied for and received Certificat es of Confidentiality for other NIH -funded 
research projects, and given the sensitive nature of the data collected for this project, do not 
foresee difficulty securing one for this study. Second, all research staff members are required to 
complete ethical clearance certification regarding protection of human’s subjects through their 
relevant IRBs. Third, all studies will have documented procedures to safeguard against the risk 
of the linking information being stolen by keeping such information in locked spaces to which 
only essential study personnel who have completed CITI certification for human subjects 
research ethics training ( http://citiprogram.org ) will have access.  
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 43 of 52 11.3 Risks and Benefits  
11.3.1  Risks  
Some participants may be uncomfortable answering questions about their past sexual behavior 
and HIV -related behaviors. All information used in enrollment and recruitment describing the 
research activities will include a detailed description of the content and expected participation of 
the respondent, suc h that the respondent is aware of the nature of the questions and topics to 
be discussed. Respondents will complete their surveys online to maximize convenience and 
privacy. Informed consent documents will inform research participants of their rights as 
participants. During the consent process, participants will be reminded that they are free to 
refuse to participate in any study activities or choose to terminate their participation at any time.  
Our consent forms will also include information on limits of confidentiality (e.g., suicidal intent, 
homicidal intent, child abuse, etc.) and mandatory reporting requirements, which will be 
reviewed by all participants.  While our surveys do not directly ask participants about child 
abuse or harm to others, it is possible that participants may volunteer this information. In such occurrences, we will follow established protocols used in our prior studies to assess risk level 
and follow -up appropriately.  
Participants will provide their name s and address es or other personally identifying information 
as part of the study. There is a risk that these data could be unintentionally disclosed to 
someone not authorized to access the data, compromising the privacy of the participant. To 
reduce this risk, all contac t information for the study participants will be kept in a password-
protected location, with access restricted to the Study Coordinators and PIs.  
Although we are not directly providing HIV testing, we are providing information on where 
participants can tes t for HIV in their locale. Participants who learn that they are HIV -positive or 
STI sero -positive may be distressed to learn of their health condition. This poses the greatest 
emotional and physical risk to participants in the research study. Given that ou r intervention 
seeks to link YMSM to HIV/STI testing locations, risks of distress are minimized by encouraging 
YMSM to receive their results at an agency that  may offer counseling and referrals.  
To minimize the risk of participants feeling uncomfortable about answering personal questions, we will use Computer Assisted Self Interview (CASI) methods for the study's surveys. In a CASI, 
participants read survey questions on a computer or mobile phone and use a combination of 
mouse click and keyboard/touchscreen entry to input the answers themselves. Participants will 
also be able to refuse to answer most  questions that make them uncomfortable.  
For mystery shoppers who evaluate testing sites, the potential risk will be minimal. There is a 
risk of untoward event s occurring during sessions that may personally affect them. Training and 
guidance will seek to minimize this risk. Additionally, a post -visit debriefing session with a 
member of the study team will help ensure any untoward events are discussed and resourc es 
are offered that may assist the mystery shopper.  
For agency directors who participate in qualitative interviews, t he potential risk will be minimal.  
There is a risk of violation of confidentiality and potential distress when discussing HIV/STI - 
related issues, but agency directors will be informed of the confidential nature of the research. 
These interviews will occur via a secure, encrypted teleconference interface ( BlueJeans ) to 
maximize security and privacy. We will remove all identifying inf ormation from quotes (agency 
names , etc.) and if quotes clearly identify an agency , they will not be included in the 
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 44 of 52 presentations of results.  
To minimize risks to confidentiality, we will secure study data with all appropriate physical, 
electronic , and operational protections. Data will be stored in a physically secure environment. 
All data files will have encryption and strong password protection. Any identifiable data will 
either be stored on Emory University's secure servers or will be on fully encrypted laptops. CASI 
surveys and online eligibility screening will take place on an encrypted commercial survey 
website, SurveyGizmo (http://www.surveygizmo.com/survey -software- features/secure -link/). 
This site has been used by the investigators for thousands o f online surveys with MSM with no 
data security breaches. Access to data will be on a role- based standard; only those study staff 
who require access to each type of data to complete their study -related roles will be allowed 
access. All study staff will be trained in security and confidentiality procedures, and will sign a confidentiality agreement before receiving access to any participant data.  
We will also develop procedures to minimize indirect disclosure that a participant is participating in an HIV - related research study, or a study that enrolls MSM. For each mode of contact 
information, we will ask specifically whether anyone else potentially has access to that mode of 
communication, and if it is acceptable to leave a non- specific message about parti cipation in a 
health study. No study -related messages will ever mention HIV prevention or the nature of the 
research study. Additionally, all scripts for email, text message, and telephone contact with 
participants will be reviewed and approved by the UNC IRB before being used for contact with 
participants.  
We use SSL encryption for transfers of information online, and SurveyGizmo has a business 
partner HIPAA agreement with Emory. SurveyGizmo’s servers are HIPAA compliant.  
The Analytic Core will use Dedoose software to perform all qualitative analyses. Dedoose is a 
web-based application for organizing and analyzing textual, audio, and video data (qualitative) 
along with outstanding functionality for their integration with survey, test score, ratings, and demographic data (quantitative). Dedoose employs the highest levels of data encryption 
available for a web application in all data storage, back up, and transmission. Dedoose allows for project specific encryption feature. When using this feature, only Dr. Kate Muessig or her 
designee will hold the additional encryption key needed to be entered in order to view the 
project. This gives Dr. Muessig exclusive control over who can view the project under any 
circumstances.  
In addition to a Certificate of Confidentiality, we will protect participants in the following ways (which correspond to the potential risks described earlier ):  
1. Breach of confidentiality. We will take every precaution to minimize risks to study participants. 
All AC research staff members ar e required to complete ethical clearance certification regarding 
protection of human subjects through UNC -CH or Emory University. W e also have an iTech U19 
Data and Safety M onitoring Plan in place to protect participants. Adverse events will be reported 
to the UNC- CH IRB, individual research PI institutional IRBs and SRV site -specific IRBs per 
each institution’s IRB reporting requirements using Adverse Event Reporting Forms created by 
the Analytic Core (AC). When possible, r eports will be sent within 24 hou rs of notification by the 
PIs. Annual updates on enrollment and retention will also be sent to the IRBs.  
All data collection will take place in secure and supervised clinical settings. All study personnel  
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 45 of 52 have completed training and received certification in Human Subjects Research Protection (CITI 
Program) and HIPAA regulations. They will continue to renew this training in compliance with 
institutional policies.  
11.3.2  Benefits   
Participants will be asked about sensitive information, and  adequate protections for internet data 
collection are in place for this study. Participants may benefit from becoming cognizant of their 
risk behaviors as they discuss HIV/AIDS and STI topics, inc luding circumstances and 
motivations behind their HIV/AIDS and STI risk behaviors and the potential to reflect on changing behaviors or taking steps to reduce risk. YMSM will have the opportunity to learn their 
own HIV status and STI results, and to receiv e information and counseling about how to reduce 
their future risk of HIV infection. All participants will receive a resource guide listing local 
HIV/STI/PrEP services, and will have the ability to be linked to care and treatment (for HIV/STI 
and PrEP serv ices). Furthermore, participation in the proposed study could potentially benefit 
participants i n a few important ways. First, it is possible that the screening, baseline, and follow -
up assessments may be beneficial to all participants by asking them to review their risk 
behaviors. Therefore, these assessments may actually serve as a very minimal intervention (as 
could any study -assessing risky behaviors). Indeed, YMSM in our prior investigations have 
commented that they have found the questions to be helpf ul. Second, all participants  in both 
conditions will receive standard of care and have an opportunity to explore their risk behaviors.  
Participants will have access to the test locator if they desire to contact  community 
organizations providing HIV/STI/PrE P education, prevention, and care services in their area. In 
sum, potential benefits for the research far outweigh the risks for the participants.   
 
Others will benefit because the study will result in increased knowledge about prevention 
interventions to serve those at highest risk for HIV infection, and benefit from a more culturally aware and competent service environment.  
 
Mystery shoppers participating in the training session and site visits may benefit from increased 
knowledge of HIV, STIs, and testing services. Additionally, they may become more savvy 
consumers of health care and gain skills around communicating with medical professionals and 
knowing how to refuse services.  
 Agency directors participating in qualitative interviews will not benefit per sonally from 
participati on in the in -depth interviews. However, they may gain some satisfaction in  knowing 
they are contributing to an important HIV prevention research effort and rec eiving feedback on 
their agency ’s performance.  
 
11.4 Institutional Review  Board (IRB) Review and Informed Consent  
 
This protocol, the informed assent/ consent documents , and any subsequent modifications will be 
reviewed and approved by the UNC IRB who is  responsible for the oversight of the study . The 
informed assent/ consent wil l describe the purpose of the study, the procedures to be followed, 
and the risks and benefits of participation.  
 
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 46 of 52  
 
11.5 Waiver of the Requirement for Signed Consent Form  
11.5.1  For Study Participation 
 
For the RCT phase of the study, once a participant is deemed eligible by completing the 
eligibility screener, he will be presented with the electronic assent/consent form. The 
assent/consent form will outline the voluntary nature of the study, YMSM ’s freedom to 
discontinue the study  at any time, approval t o retain email addresses for future study 
opportunities, and the procedures to guarantee their confidentiality. The assent/consent form includes a yes/no checkbox option instead of signature lines. For the Mystery Shopper phase, 
once a participant is deemed eligible by completing the eligibility screener, he will be presented 
with a hard copy of the consent form to sign. The assent/consent form will outline the voluntary 
nature of the study, YMSM’s freedom to discontinue the study at any time, approval to r etain 
email addresses for future study opportunities, and the procedures to guarantee their confidentiality. Email addresses of the participants who agree to the content of the 
assent/consent will be stored in a password- protected file housed within a secure, encrypted 
sever at the University of Pennsylvania School of Nursing and only available to designated study staff.  
 
11.5.2 For Eligibility Screening  
The screening presents minimal risk to participants and involves no procedures that would 
require written consent outside of a research context . Under these conditions the IRB is 
authorized to modify the requirements to obtain a signed consent form for some or all 
participants  (45 CFR 46.117 [c]).  
 
Potential participants will enter a link to a website that is  listed on recruitment materials and 
begin by completing a short eligibility screener . If found eligible, participants will then be directed 
to a page to provide their contact information.  For those who do not meet eligibility criteria, there 
will b e an option to provide a first name and email address if they want to be contacted about 
future studies.   
 
11.6  Prisoner Participation  
NICHD has  concluded that this protocol does NOT meet Federal requirements governing 
prisoner participation in human subject research and should NOT be considered by local IRBs 
for the recruitment of prisoners. Participants  enrolled who subsequently become incarcera ted or 
are placed in detention may not continue study participation. Study visits cannot be conducted 
during the period of incarceration or detention.  
 
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 47 of 52 11.7 45 CFR Parts 160 and 164 Standards for Privacy of Individually Identifiable Health  
Information ("P rivacy Rule" Pursuant to the Health Insurance Portability and Accountability Act -  
HIPAA)  
Each site is responsible for adherence to their individual institution’s HIPAA policies and 
procedures.  
 
11.8 Study Discontinuation  
This study may be discontinued at any time by the UNC IRB, NICHD, or other government 
agencies as part of their duties to ensure that research participants are protected .  
 
12.0 PUBLICATION OF RESEA RCH FINDINGS  
Any presentation, abstract , or manuscript will be made available for review by the study 
sponsor (s) prior to submission.  
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 48 of 52 13.0 REFERENCES 
 
1. Johnson AS, Hall HI, Hu X, Lansky A, Holtgrave DR, Mermin J. Trends in diagnoses of 
HIV infection in the United States, 2002- 2011. JAMA. 2014;312(4):432- 434. 
2. CDC. HIV and Young Men Who Have Sex With Men. 2015; 1- 4. Available at: 
http://www.cdc.gov/healthyyouth/sexualbehaviors/pdf/hiv_factsheet_ymsm.pdf . 
3. Wejnert C, Le B, Rose CE, et al. HIV infection and awareness among men who have sex 
with men -20 cities, United States, 2008 and 2011. PLoS One. 2013;8(10):e76878.  
4. Kubicek K, Arauz -Cuadra C, Kipke MD. Attitudes and Perceptions of Biomedical HIV 
Prevention M ethods: Voices from Young Men Who Have Sex with Men. Archives of 
Sexual Behavior. 2015;44:487- 497. 
5. Eaton LA, Driffin DD, Bauermeister J, Smith H, Conway -Washington C. Minimal 
awareness and stalled uptake of Pre -Exposure Prophylaxis (PrEP) among at risk, HI V-
negative, black men who have sex with men. AIDS Patient Care STDs. 2015;29(8):423 -
430. 
6. Bauermeister JA, Meanley S, Pingel E, Soler JH, Harper GW. PrEP Awareness and 
Perceived Barriers Among Single Young Men who have Sex with Men. Curr Hiv Res. Oct 
2014;11(7):520 -527. 
7. Buchbinder S, Liu A. Pre- Exposure Prophylaxis and the Promise of Combination 
Prevention Approaches. AIDS and Behavior. 2011;15:72 -79. 
8. CDC. Pre -exposure prophylaxis (PrEP) for HIV prevention: Promoting safe and effective 
use in the United Stat es. 2011.  
9. Grant RM, Lama JR, Anderson PL, et al. Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men. New England Journal of Medicine. 
2010;363:2587 -2599.  
10. Hoots BE, Finlayson TJ, Wejnert C, Paz -Bailey G, Group NS. Early Linkage to HIV Care 
and Antiretroviral Treatment among Men Who Have Sex with Men--20 Cities, United 
States, 2008 and 2011. PLoS One. 2015;10(7):e0132962.  
11. Harper GW. Sex isn't that simple: culture and context in HIV prevention interventions for 
gay and bisexual male adolescents. The American psychologist. Nov 2007;62(8):803- 819. 
12. Sumartojo E, Lyles C, Choi K, et al. Prevalence and correlates of HIV testing in a multi -
site sample of young men who have sex with men. AIDS care. 2008;20:1- 14. 
13. Grossman CI, Forsyth A, Purcell  DW, Allison S, Toledo C, Gordon CM. Advancing Novel 
HIV Prevention Intervention Research with MSM -Meeting Report. Public Health Reports. 
2011;126:472 -479. 
14. Harper GW, Riplinger AJ. HIV prevention interventions for adolescents and young adults: 
what about t he needs of gay and bisexual males? AIDS and behavior. Mar 
2013;17(3):1082 -1095.  
15. Harper GW, Willard N, Ellen J, the ATN. Connect to Protect(R): Utilizing community 
mobilization and structural change to prevent HIV infection among youth. Journal of 
Preventi on and Intervention in the Community. 2013;40:81 -86. 
16. Garofalo R, Harper GW. Not all adolescents are the same: addressing the unique needs of gay and bisexual male youth. Adolescent medicine (Philadelphia, Pa.). 2003;14:595 -
611, vi.  
17. Harper GW, Riplinger AJ.  HIV Prevention Interventions for Adolescents and Young Adults: 
What About the Needs of Gay and Bisexual Males? AIDS and behavior. 2013;17:1082 -
1095.  
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 49 of 52 18. Hightow -Weidman LB, Muessig KE, Bauermeister J, Zhang C, LeGrand S. Youth, 
Technology, and HIV: Recent Adv ances and Future Directions. Current HIV/AIDS 
Reports. 2015;12(4):500 -515. 
19. Allison S, Bauermeister Ja, Bull S, et al. The intersection of youth, technology, and new 
media with sexual health: moving the research agenda forward. The Journal of adolescent 
health : official publication of the Society for Adolescent Medicine. 2012;51:207- 212. 
20. WhiteHouse. National HIV/AIDS Strategy for the United States2010; Washington D.C.  
21. Bauermeister JA, Pingel ES, Jadwin- Cakmak L, et al. The use of mystery shopping for 
qualit y assurance evaluations of HIV/STI testing sites offering services to young gay and 
bisexual men. AIDS Behav. Oct 2015;19(10):1919- 1927.  
22. Harper GW, Schneider M. Oppression and discrimination among lesbian, gay, bisexual, and Transgendered people and communities: a challenge for community psychology. 
American journal of community psychology. Jun 2003;31(3 -4):243- 252. 
23. Hosek SG, Harper GW, Lemos D, Martinez J. An Ecological Model of Stressors Experienced by Youth Newly Diagnosed With HIV. Journal of HIV/AIDS prevention in 
children & youth. 2008;9(2):192 -218. 
24. Hussen SA, Harper GW, Bauermeister JA, Hightow -Weidman LB. Psychosocial 
influences on engagement in care among HIV -positive young black gay/bisexual and other 
men who have sex with men.  AIDS Patient Care STDs. 2015;29(2):77- 85. 
25. Ziff MA, Harper GW, Chutuape KS, et al. Laying the foundation for Connect to Protect: a multi- site community mobilization intervention to reduce HIV/AIDS incidence and 
prevalence among urban youth. Journal of urban health : bulletin of the New York 
Academy of Medicine. May 2006;83(3):506- 522. 
26. Ziff Ma, Willard N, Harper GW, Bangi AK, Johnson J, Ellen JM. Connect to Protect 
Researcher -Community Partnerships: Assessing Change in Successful Collaboration 
Factors over T ime. Global journal of community psychology practice. 2010;1:32 -39. 
27. Lenhart A. Teens, Social Media & Technology -  Overview 2015. Internet, Science & Tech  
2015; http://www.pewinternet.org/2015/04/09/teens -social -media- technology -2015/
. 
Accessed December 15, 2015.  
28. Cozier N. Geo -location, collaboration, MHealth & More: Navigating HIV prevention and 
services across the federal government with one simple tool. 2011 CD C National 
Conference on Health Communication, Marketing and Media. Atlanta, Georgia: Centers 
for Disease Control and Prevention; 2011.  
29. Beardsell S, Coyle A. A review of research on the nature and quality of HIV testing 
services: A proposal for process -based studies. Social Science and Medicine. 
1996;42:733 -743. 
30. Worthington C, Myers T. Desired elements of HIV testing services: test recipient 
perspectives. AIDS Patient Care STDs. 2002;16:537- 548. 
31. Calabrese SK, Earnshaw Va, Underhill K, Hansen NB, Dovidio JF.  The impact of patient 
race on clinical decisions related to prescribing HIV pre- exposure prophylaxis (PrEP): 
Assumptions about sexual risk compensation and implications for access. AIDS and 
Behavior. 2014;18:226 -240. 
32. Knight RE, Shoveller Ja, Carson aM, Contreras -Whitney JG. Examining clinicians' 
experiences providing sexual health services for LGBTQ youth: considering social and 
structural determinants of health in clinical practice. Health Education Research. 
2014;29:662 -670. 
33. Tanner AE, Philbin MM, Duval A, et al. "Youth friendly" clinics: considerations for linking and engaging HIV -infected adolescents into care. AIDS Care. Feb 2014;26(2):199- 205. 
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 50 of 52 34. Bauermeister JA, Eaton L, Andrzejewski J, Loveluck J, VanHemert W, Pingel ES. Where 
You Live Matters: Structural Correlates of HIV Risk Behavior Among Young Men Who 
Have Sex with Men in Metro Detroit. AIDS Behav. Dec 2015;19(12):2358- 2369.  
35. Jeffries WL, Townsend ES, Gelaude DJ, Torrone Ea, Gasiorowicz M, Bertolli J. HIV Stigma Experienced by Young Men Who Have Sex  With Men (MSM) Living With HIV 
Infection. AIDS Education and Prevention. 2015;27:58- 71. 
36. Dittus PJ, De Rosa CJ, Jeffries Ra, et al. The Project Connect Health Systems Intervention: Linking Sexually Experienced Youth to Sexual and Reproductive Health 
Care. Journal of Adolescent Health. 2014.  
37. Chavez NR, Shearer LS, Rosenthal SL. Use of digital media technology for primary prevention of STIs/HIV in youth. Journal of pediatric and adolescent gynecology. Oct 
2014;27(5):244 -257. 
38. Muessig KE, Nekkanti M, Bauermeist er J, Bull S, Hightow -Weidman LB. A Systematic 
Review of Recent Smartphone, Internet and Web 2.0 Interventions to Address the HIV 
Continuum of Care. Current HIV/AIDS Reports. 2015.  
39. Bauermeister JA, Pingel ES, Jadwin- Cakmak L, et al. Acceptability and preli minary 
efficacy of a tailored online HIV/STI testing intervention for young men who have sex with 
men: the Get Connected! program. AIDS Behav. Oct 2015;19(10):1860 -1874.  
40. Sullivan P, Sineath C, Kahle E, Sanchez T. Awareness, willingness and use of oral PrEP  
among a national sample of US men who have sex with men. AIDS Impact . 
Amsterdam2015.  
41. Social cognition models and health behaviour: A structured review, Psychology & Health(2000).  
42. An extension of the theory of reasoned action and its successors to multiple behavior 
interventions, 53-67(Lawrence Erlbaum Associates Publishers 2007).  
43. Deci EL, Eghrari H, Patrick BC, Leone DR. Facilitating internalization: the self -
determination theory perspective. Journal of personality. 1994;62:119 -142. 
44. Ryan RM, Deci EL. Self -determination theory and the facilitation of intrinsic motivation, 
social development, and well -being. The American psychologist. 2000;55:68- 78. 
45. Herbst JH. Recommendations for use of behavioral interventions to reduce the risk of 
sexual transmission of HIV  among men who have sex with men. American journal of 
preventive medicine. 2007;32:S36- S37. 
46. Naar -King S, Parsons JT, Johnson AM. Motivational interviewing targeting risk reduction 
for people with HIV: A systematic review. Current HIV/AIDS Reports. 2012;9:335- 343. 
47. Stone AL, Becker LG, Huber AM, Catalano RF. Review of risk and protective factors of substance use and problem use in emerging adulthood. Addictive Behaviors. 
2012;37:747 -775. 
48. Noar SM, Palmgreen P, Chabot M, Dobransky N, Zimmerman RS. A 10- year sys tematic 
review of HIV/AIDS mass communication campaigns: Have we made progress? Journal 
of health communication. 2009;14:15- 42. 
49. Applying Theory to Culturally Diverse and Unique Populations, 485- 509(Jossey -Bass 
2002).  
50. Resnicow K, DiIorio C, Soet JE, Ernst D , Borrelli B, Hecht J. Motivational interviewing in 
health promotion: it sounds like something is changing. Health psychology : official journal 
of the Division of Health Psychology, American Psychological Association. 2002;21:444-
451. 
51. Miller WR, Rollnick S. Motivational Interviewing: Helping People Change. 2012.  
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 51 of 52 52. Teitcher JEF, Bockting WO, Bauermeister JA, Hoefer CJ, Miner MH, Klitzman RL. 
Detecting, preventing, and responding to "fraudsters" in internet research: Ethics and 
tradeoffs. J. Law Med. Ethics. 2 015;43(1):116 -133. 
53. Bauermeister J, Pingel E, Zimmerman M, Couper M, Carballo- Dieguez A, Strecher VJ. 
Data Quality in web- based HIV/AIDS research: Handling Invalid and Suspicious Data. 
Field methods. Aug 1 2012;24(3):272 -291. 
54. Qualtrics. Security Statement.  https://www.qualtrics.com/security -statement/ . Accessed 
1/11, 2017.  
55. Braun V, Clarke V. Using thematic analysis in psychology. Qualitative research in 
psychology. 2006;3:77- 101. 
56. The identificati on and analysis of themes and patterns., 189 -210(Sage 1994).  
57. Bauermeister JA, Meanley S, Pingel E, Soler JH, Harper GW. Prep awareness and 
perceived barriers among single young men who have sex with men. Curr Hiv Res. 
2013;11(7):520 -527. 
58. Mustanski B, Johnson AK, Garofalo R, Ryan D, Birkett M. Perceived likelihood of using 
HIV pre -exposure prophylaxis medications among young men who have sex with men. 
AIDS Behav. Jul 2013;17(6):2173- 2179.  
59. Fisher CM. Are Information, Motivation, and Behavior al Skills Linked with HIV -Related 
Sexual Risk among Young Men Who Have Sex with Men? J HIV AIDS Soc Serv. Winter 
2011;10(1):5 -21. 
60. Meadowbrooke CC, Veinot TC, Loveluck J, Hickok A, Bauermeister Ja. Information 
behavior and HIV testing intentions among young men at risk for HIV/AIDS. Journal of the 
Association for Information Science and Technology. 2014;65:609 -620. 
61. Carballo -Diéguez a, Dolezal C, Ventuneac a. Sexual Practices Assessment Schedule. 
New York: HIV Center for Clinical and Behavioral Studies, Colum bia University & New 
York State Psychiatric Institute; 2002.  
62. Bauermeister JA. Sexual Partner Typologies Among Single Young Men Who Have Sex 
with Men. AIDS Behav. Jun 2015;19(6):1116- 1128.  
63. Bauermeister JA, Zimmerman MA, Johns MM, Glowacki P, Stoddard S, Vol z E. Innovative 
recruitment using online networks: lessons learned from an online study of alcohol and 
other drug use utilizing a web- based, respondent -driven sampling (webRDS) strategy. 
Journal of studies on alcohol and drugs. Sep 2012;73(5):834 -838. 
64. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early 
Detection of Persons with Harmful Alcohol Consumption-- II. Addiction (Abingdon, 
England). 1993 ;88:791 -804. 
65. Derogatis LR, Melisaratos N. The Brief Symptom Inventory: an introductory report. 
Psychological medicine. 1983;13:595 -605. 
66. Rosenberg M. Society and the adolescent self -image. Princeton, NJ: Princeton University 
Press; 1965.  
67. Kahana SY, Fernandez MI, Wilson PA, et al. Rates and correlates of antiretroviral therapy 
use and virologic suppression among perinatally and behaviorally HIV -infected youth 
linked to care in the United States. J. Acquired Immune Defic. Syndr. 2015;68(2):169 -177. 
68. Philbin MM,  Tanner AE, DuVal A, et al. Factors affecting linkage to care and engagement 
in care for newly diagnosed HIV -positive adolescents within fifteen adolescent medicine 
clinics in the United States. AIDS Behav. Aug 2014;18(8):1501 -1510.  
ATN 139 -  Get Connected!   Version 2. 4_01-Feb-2019  
 Page 52 of 52 69. Fortenberry JD, Martine z J, Rudy BJ, Monte D, Adolescent Trials Network for HIVAI. 
Linkage to care for HIV -positive adolescents: a multisite study of the adolescent medicine 
trials units of the adolescent trials network. J Adolesc Health. Dec 2012;51(6):551- 556. 
70. Brooke J. SUS: a  "quick and dirty‟ usability scale. In: P J, B T, B W, I M, eds. Usability 
Evaluation in Industry . London: Taylor & Francis; 1996:189 -194. 
71. Veinot TC, Meadowbrooke CC, Loveluck J, Hickok A, Bauermeister JA. How community 
matters for how people interact with information: Mixed methods study of young men who 
have sex with other men. Journal of Medical Internet Research. 2013;15:e33.  
72. Bauermeister JA, Leslie- Santana M, Johns MM, Pingel E, Eisenberg A. Mr. Right and Mr. 
Right Now: romantic and casual partner -seek ing online among young men who have sex 
with men. AIDS Behav. Feb 2011;15(2):261- 272. 
73. Winetrobe H, Rice E, Bauermeister J, Petering R, Holloway IW. Associations of 
unprotected anal intercourse with Grindr -met partners among Grindr -using young men 
who have sex with men in Los Angeles. AIDS Care. 2014;26(10):1303 -1308.  
74. Patton MQ. Qualitative evaluation and research methods. Qualitative Inquiry. 
2001;3rd:598.  
75. Boyatzis RE. Transforming qualitative information: Thematic analysis and code 
development. Transformin g Qualitative Information Thematic Analysis and Code 
Development. 1998:184.  
76. Diggle PJ, Liang KY, Zeger SL. Analysis of longitudinal data. Oxford: Clarendon Press, 
1994, pages 68- 77.  